Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Improving Medication Compliance in Geriatric Patients
Submitted by
Eva M Jacques
Direct Practice Improvement Project Proposal
Doctor of Nursing Practice
Grand Canyon University
Phoenix, Arizona
May 27, 2020
© by Eva Mireille Jacques, 2020
All rights reserved.
GRAND CANYON UNIVERSITY
Improving Medication Compliance in Geriatric Patients
by
Eva M. Jacques
Has been approved
May 27, 2020
APPROVED:
Tabitha Garbart, DNP, DPI Project Chairperson
Hubert Cantave, MD, Committee Member
ACCEPTED AND SIGNED:
________________________________________Lisa Smith, PhD, RN, CNEDean and Professor, College of Nursing and Health Care Professions
_________________________________________Date
iv
Abstract
Many geriatric patients suffer from one or more chronic diseases and the management of
those chronic conditions may require one or more prescribed medications. Medication
compliance is essential in the treatment of chronic illness and unfortunately poor
compliance in the geriatric population is extensive. The purpose of this quantitative
quasi-experimental project was to determine if or to what degree the implementation of a
weekly phone call using the Hill Bone medication adherence scale (HB-MAS) would
impact medication compliance among geriatric patients in a private clinic in the
southeastern United States over six-weeks. The health belief model was utilized to
evaluate if a weekly phone call along with the administration of a HB-MAS would
motivate participants to increase medication compliance. The population was of geriatric
patients’ 65 to 82 years of age. The total sample size was n= 60 of patients, n=30 in the
comparative group and n = 30 in the implementation group. The data was collected from
the HB-MAS. The analysis of the data was done utilizing the Shapiro-Wilk test. The
results of the Shapiro-Wilk test showed that the data of the MAS scores at pre-test for
both intervention group (SW(30) = 0.95, p = 0.14) and non-intervention group (SW(30) =
0.95, p = 0.12) followed normal distribution while only the data of the MAS scores at
post-test for the non-intervention (SW(30) = 0.94, p = 0.11) followed normal distribution
which means statically there was significant improvement in compliance. It is
recommended that future investigator who may want to duplicate this project utilizes a
much larger sample size for a longer time period also a more diverse group of
participants.
Keywords: Geriatric; Medication Compliance; Noncompliance.
v
Dedication
This project is dedicated to my family who supported me throughout this
endeavor. To my husband, Daniel thank you. I love you. I hope I have made you proud.
To my sons Evan and Jordan, I hope my achievement proved to you that you can do and
be anything you want in life if you work hard at it. Noting is impossible. I love you both
immensely.
vi
Acknowledgments
I would like to acknowledge my mentors, Dr. Hubert Cantave and Dr. Mayre
Urdaneta for their guidance and support towards the completion of this program. To my
dear friend and colleague Guerna Blot who supported, motivated, and pushed me when I
thought it was impossible to go on. Guerna, I thank you from the bottom of my heart. To
my friend Deborah Williams, who went above and beyond to assist me with obtaining
forms and signatures needed allowing continue moving forward in the program, I thank
you from the bottom of my heart and I am forever grateful. I want to thank the
administrators of my current place of employment for their support and allowing me to
accomplish this goal. Thank you very much.
vii
Table of Contents
viii
List of Tables......................................................................................................................xi
List of Figures....................................................................................................................xii
Chapter 1: Introduction to the Project..................................................................................1
Background of the Project.............................................................................................3
Problem Statement.........................................................................................................4
Purpose of the Project....................................................................................................5
Clinical Questions..........................................................................................................7
Advancing Scientific Knowledge..................................................................................8
Significance of the Project.............................................................................................9
Rationale for Methodology..........................................................................................10
Nature of the Project Design........................................................................................11
Definition of Terms......................................................................................................12
Assumptions, Limitations, Delimitations....................................................................13
Summary and Organization of the Remainder of the Project......................................14
Chapter 2: Literature Review.............................................................................................16
Theoretical Foundations...............................................................................................18
Review of the Literature..............................................................................................22
Barriers to adherence.....................................................................................24
Utilization of mobile technology to enhance adherence................................27
Summary......................................................................................................................31
Chapter 3: Methodology....................................................................................................33
Statement of the Problem.............................................................................................34
Clinical Question.........................................................................................................34
ix
Project Methodology....................................................................................................36
Project Design..............................................................................................................37
Population and Sample Selection.................................................................................38
Instrumentation or Sources of Data.............................................................................40
Validity........................................................................................................................41
Reliability.....................................................................................................................42
Data Collection Procedures..........................................................................................43
Data Analysis Procedures............................................................................................44
Ethical Considerations.................................................................................................46
Limitations...................................................................................................................48
Summary......................................................................................................................49
Chapter 4: Data Analysis and Results................................................................................51
Descriptive Data...........................................................................................................52
Data Analysis Procedures............................................................................................54
Results..........................................................................................................................55
Summary......................................................................................................................67
Chapter 5: Summary, Conclusions, and Recommendations..............................................68
Summary of the Project...............................................................................................69
x
Summary of Findings and Conclusion.........................................................................70
Implications..................................................................................................................72
Theoretical implications.................................................................................73
Practical implications.....................................................................................73
Future implications........................................................................................74
Recommendations........................................................................................................75
Recommendations for future projects............................................................75
Recommendations for practice......................................................................76
Summary......................................................................................................................77
References..........................................................................................................................79
Appendix A......................................................................................................................101
Appendix B......................................................................................................................102
Appendix C......................................................................................................................103
xi
List of Tables
Table 1. Descriptive Statistics Summaries of MAS Scores at Pre-test and Post-test……57
Table 2. Shapiro-Wilk Test of Normality of Data of Dependent Variables……………..61
Table 3. Levene’s Test of Homogeneity of Variances…………………………………. 63
Table 4. Repeated Measures ANOVA Results on MAS Scores………………………..65
xii
List of Figures
Figure 1. Participants' Gender …………………………………………………………...53
Figure 2. Number of Chronic Illnesses………………………………………………….53
Figure 3. Participants' Age………………………………………………………………54
Figure 4. Participants Education Level………………………………………………….54
Figure 5. MAS Score at Pre-Test………………………………………………………..59
Figure 6. MAS Score at Post-Test……………………………………………………....59
1
Chapter 1: Introduction to the Project
Medication adherence is essential in the treatment of chronic diseases. Medication
adherence occurs when the patient takes the medication as prescribed (Smith et al., 2017).
Non-adherence in the management of chronic conditions is a major concern because
continuous treatment is essential for effective disease management. Raghupathi and
Raghupathi (2018) defined chronic condition as a physical or mental health condition
lasting more than one year and causing functional restrictions or requiring ongoing
monitoring or treatment. Lack of compliance with a medication regimen can lead to
worsening of symptoms and may lead to new complications. Treatment efficacy depends
on the patient’s compliance. Effective management of chronic comorbid conditions often
involves complex medication regimens, requiring different tablet combinations and
multiple daily dosing that can lead to a high rate of noncompliance to medication
regimens (Smith et al., 2017).
Aging is a strong risk factor for many chronic diseases (Pagès-Puigdemont et al.,
2016). According to the Global Health and Aging report presented by the World Health
Organization (WHO), the number of people aged 65 or older is projected to grow from an
estimated 524 million in 2010 to nearly 1.5 billion in 2050, with most of the increase in
developing countries (Pagès-Puigdemont et al., 2016). America’s current demographics
indicate 10,000 Americans will turn 65 each day from now through the end of 2029
(Raghupathi & Raghupathi, 2018). Hence, in the United States, the number of people 65
years or older is expected to significantly increase. Therefore, the overall number of
patients with multiple diseases may significantly increase, and some patients may be
taking one or more medications to manage multiple chronic conditions.
2
Multiple medications increase the likelihood of poor adherence among geriatric
patients. Mcmullen et al. (2014) reported that more than half of American adults take at
least one prescription drug, and one out of 10 take five or more. Qato et al. (2016) noted a
higher prevalence and used a representative sample of 2,206 adults aged 62 through 85
years of age. Their study showed 87% of geriatric patients used at least one prescription
medication. About 36% of geriatric patients used at least five prescription medications,
while 38% used over-the-counter medication. Patients who take medications
inappropriately can face serious side effects, even including fatality. Medication
noncompliance is a major health problem; it accounts for 10% of all hospital stays and
causes approximately 125,000 deaths each year (Mayo & Mouton, 2017).
Several studies have shown that lack of adherence among the older adult
population represents a significant problem and has led to increased morbidity, mortality,
and healthcare cost (Jin, Kim, & Rhie, 2016; Marcucci et al., 2010; Yap, Thirumoorthy,
& Kwan, 2016). Researchers have identified improving adherence to medication as one
of the most cost-effective and achievable opportunities for improving health outcomes
(Nguyen, La Caze, & Cottrell, 2016). There is a need to recognize factors related to
nonadherence to medication, as providers and clinicians can then use findings to
strategize and formulate individual interventions that can increase compliance, thereby
improving patient outcomes( Karakurt, & Kaşikçi, 2012).
The Direct Practice Improvement (DPI) PICOT question is the following: With
geriatric patients with chronic illnesses who are noncompliant with their medication
regimen, how does the implementation of a weekly phone call and the administration of
an HB-MAS improve compliance comparing to those who do not participate over a
period of 6 weeks? The MAS was used to measure compliance. The information obtained
3
from this scale was used to counsel patients regarding the importance of medication
adherence. This tool was developed, in part, as a response to earlier instruments, such as
the Medication Adherence Questionnaire (MAQ) by Morisky, Green, and Levine (1986).
Researchers used the MAQ to measure medication adherence for hypertension treatment
and psychometric properties. The MAQ scale appeared adequate in Morisky et al.’s
(1986) study; as the researchers measured patients’ self-reported compliance. Toll et al.
(2007) posited that researchers could use the MAQ to help health practitioners address
the side effects of mediation proactively, thus addressing medical challenges by the
geriatric population.
The organization of this chapter is in various sections. First, the background of the
project shows both the history and the problem. The problem is discussed as well as to
the problem statement and the significance of the project. The selection of the
methodology is presented, along with the nature of the project design, definitions, and
limitations of the project.
Background of the Project
The geriatric population is prone to chronic illnesses, such as hypertension,
diabetes, arthritis, neurodegenerative, gastrointestinal, ocular, genitourinary, and
respiratory disorders, which may require chronic medication with multiple drugs. Poor
compliance in this age group is common (Patton, Hughes, Cadogan, & Ryan, 2017).
Failure to follow prescription medication can be costly to both the patient and the
healthcare system. Many geriatric patients have chronic conditions, such as the diseases
mentioned, which are poorly controlled due to noncompliance.
Noncompliance with the medication regimen is a major health problem,
especially in the geriatric population (Mayo & Mouton, 2017). Non-adherence to
4
prescribed medication does not only threaten patient health but also contributes to the
increasing costs of health care in the United States. Noncompliance is a major cause of
disease exacerbation and treatment failure. According to Cutler et al. (2018), annual
costing of medication non-adherence ranges from $100 to $290 billion in the United
States; hence, researchers should consider medication compliance as crucial in the
geriatric population.
Currently, increases have occurred in geriatric patients arriving at their primary
care providers with extremely elevated blood pressures and blood glucose levels.
Consequently, these issues have led to an increase in patients using healthcare services,
such as urgent care centers and emergency rooms. Thus, finding effective ways to
increase medication compliance among the geriatric population is essential in improving
their quality of life.
Problem Statement
It was not known if or to what extent a weekly phone call and the administration
of MAS can increase medication compliance among the geriatric patients. Finding a way
to increase compliance through communication, education, and encouragement may
reduce hospitalization rate and thereby improve quality of life (Jin et al. 2016). Compared
to young adults, the healthcare needs of the geriatric patients are diverse and complex due
to comorbidities and the need for multiple medications, as described by Lam and Fresco
(2015). Clinicians may use the findings of this project to assist geriatric patients in the
clinic with increasing compliance with their prescribed medications and increase
awareness of their chronic disease processes.
A quantitative study of more than 75,000 commercially insured patients showed
that 30% failed to fill a new prescription, also new prescriptions for chronic conditions,
5
such as high blood pressure, diabetes, and high cholesterol, were not filled 20% to 30%
of the time (Miller, 2016). In a study African Americans, aged 65 years and older taking
an average of 5.7 medications, it was discovered that patients could not identify the
purpose of at least one of their medications over 56% of the time. The results of this
multivariate analysis showed that copayment for drugs, memory deficits, Medication
Regimen Complexity Index (MRCI), and medication-related knowledge were all
associated with adherence to a medication regimen. Miller (2016) found that participants
with a higher level of knowledge about therapeutic purpose and knowledge about the
dosage regimen of their medications were seven times (Confidence Interval: 4.2–10.8)
more likely to adhere to frequency and dose of medications. Conversely, participants with
a low complexity index were two times (Confidence Interval: 1.1–3.9) more likely to
adhere to the dosage regimen of their medications, compared with participants with a
high drug regimen complexity index.
Non-adherence to a medication regimen is complex and it will take the
collaboration of providers and patients to formulate individualized plans to arrive at
compliance. The road to compliance starts with a multidimensional and multidisciplinary
approach. Providers play a pivotal role in encouraging their patients to be compliant by
utilizing evidence-based practice strategies tailored to improving compliance. From the
literature reviewed, noncompliance in the geriatric population is a major health problem.
Lack of adherence causes nearly 125,000 deaths and 10% of hospitalizations while
costing the already strained healthcare system between 100 to 289 billion dollars a year
(Mayo & Mouton 2017).
6
Purpose of the Project
The purpose of this quantitative direct practice improvement project was to
evaluate if an intervention, such as a weekly phone call with the administration of a
MAS, can increase medication compliance in the geriatric patient population. The project
compared compliance between two groups of participants. Those that received a weekly
phone call and answer the questions of the MAS versus participants that did not receive a
phone call. The goal of this project was to increase medication compliance in the geriatric
patient population seen at a private clinic located in the Southeastern United States. This
project intended to provide a way to aid providers with assisting the geriatric patient with
improving compliance with their medication regimen. Such compliance can be clinically
beneficial, given the complexity of managing geriatric patients with chronic conditions.
The focus of the project was to provide healthcare providers with an opportunity
to help geriatric patients with medication compliance. According to Huang et al. (2013),
mobile phone technology using text messages has been shown to be useful to improve
adherence rates. However, previous studies reported that participants prefer interventions
that not only act as a reminder but also allows them to enquire about their illness or
simply to communicate with their providers. Thus, practitioners must see every patient
interaction as an opportunity to educate patients about their disease process and
encourage compliance with the medication regimen. The independent variable was the
implementation of a weekly phone call and the completion of an HB- MAS. The weekly
phone call not only served as a reminder for patients to take their medications but also
encouraged them to ask questions they may have at that time about their disease process
and their medications. The dependent variable was the degree of compliance, as indicated
7
by data analysis from the MAS, the comparison of pre- and post-intervention, and also
the normalization of clinical values.
Clinical Questions
Looking for strategies to improve process aiming at improving compliance among
the geriatric population is crucial. Healthcare providers must strategize to find means of
improving processes to increase compliance among the geriatric population. Thus,
identifying methods that can influence geriatric patients at being compliant will
significantly decrease the rate of negative outcomes related to poor compliance in the
geriatric population
The PICOT question to be answered: With geriatric patients with chronic
illnesses who are noncompliant with their medication regimen, how does the
implementation of a weekly phone call and the administration of an HB-MAS improve
compliance comparing to those who do not participate over a period of 6 weeks? The
specific clinical questions are as follows:
For this project, the quantitative quasi-experimental method was used to answer
the following questions:
Q1: To what degree does the implementation of an HB-MAS via weekly phone
call increase medication compliance among geriatric patients with chronic
diseases?
Q2: What is the relationship between the patients who are participating in the
weekly MAS and the patients who are not participating?
The clinical questions determined if there is a relationship between the weekly
phone call and increase in medication compliance in geriatric patients between the age of
65 to 82 years old who suffers from at least one chronic condition. The weekly phone
8
call was the independent variable, while the increased compliance rate with medication
regimen among geriatric patients was the dependent variable.
Advancing Scientific Knowledge
Patients who increase compliance with a medication regimen can prevent
undesirable health outcomes. Geriatric patients must learn the importance of taking their
prescribed medications as ordered. Therefore, healthcare providers must take every
opportunity to explain the potential untoward effects of noncompliance to geriatric
patients. Many factors may be associated with patients’ noncompliance; thus, providers
should investigate the reason for noncompliance to be able to successfully intervene.
Originally, Becker (1974) used the health belief model (HBM) to demonstrate the
relationship between health beliefs and health behaviors, assuming that preventive
behaviors depend on the individual’s beliefs. Modern researchers have used the model to
investigate various health issues (Luquis & Kensinger, 2019; Mirhoseni, Mazloomy, &
Moqaddasi Amiri, 2019). Mirhoseni et al. (2019) used the HBM to study blood pressure
in Yazd, while Luquis and Kensinger (2019) used the HBM to study prevention services
that leadership used to help young adults. Others have used the HBM in different studies.
Researchers have used the HBM to investigate behavioral changes and disease
prevention in geriatric patients (Baktash & Naji, 2019; Yazdanpanah, Saleh Moghadam,
Mazlom, Haji Ali Beigloo, & Mohajer, 2019). Baktash and Naji (2019) used the HBM to
encourage more exercise behavior among geriatric home residents to prevent stroke.
Yazdanpanah et al. (2019) used the HBM to study elderly patients’ medication adherence
to develop strategies to encourage more use of medications among this population. For
this project, this model’s constructs were used to identify barriers to compliance and
provide an understanding of the lack of compliance with geriatric patients. The acquired
9
knowledge will be beneficial and necessary to formulate plans for interventions, thereby
improving outcomes.
Significance of the Project
Multiple studies on medication adherence since the ’60s have focused on quality
improvement initiatives that placed more emphasis on practice routine, care
recommendations, and guidelines. For instance, clinicians can ensure that patients with
chronic conditions receive their prescribed medications to demonstrate improvement in
health outcomes (BrarPrayaga et al., 2018). However, clinicians should focus on
confirming that the patients take their prescribed medications as ordered for positive
treatment outcomes. Previous research has shown that adherence to medications is related
to reduce the risk of a poor outcome by 26% (Toll et al., 2007). Thus, ensure patients
with chronic conditions consistently take their prescribed medications to prevent the
progression of the disease.
The independent variable was the weekly phone call with an HB-MAS. The
weekly call not only reminded patients to take their medications as prescribed but l also
encouraged them to ask questions about their medications. The dependent variable was
the degree of weekly compliance, which was measured using the HB-MAS.
The goal of the project was to increase medication compliance with the geriatric
population and provide healthcare providers with an evidence-based opportunity to help
geriatric patients with medication compliance. The result of this project can make a
significant impact on the individual patient as clinicians can use findings to improve
patient outcomes. According to Jin et al. (2016), being compliant with the medication
regimen can contribute to the alleviation of symptoms, reduction of morbidity and
mortality rates, reduction of risk of side effects, and reduction of the burden on health
10
care costs. This project is significant to the healthcare facility because of the population
served, are older adults. The investigator emphasized the importance of adherence to
medication and revealed ways through which adherence can be improved among the
geriatric patients served. The findings translated into decreased emergency room visits,
office visits, and hospitalizations.
Rationale for Methodology
A quantitative quasi-experimental comparison design was selected for this
project. This method was used to determine if the implementation of weekly phone calls
and the administration of a MAS would increase medication compliance among geriatric
patients. Several participants were selected through convenience sampling. They were
patients in private clinics who admitted noncompliance. The inclusion criteria were of
patients who are 65 to 82 years of age, have at least one chronic disease, do not exhibit
any cognitive impairment, and have access to a phone. The exclusion criteria were of
patients who had no chronic disease, cognitively impaired, or have no access to a phone.
The selected participating patients were divided into two groups of 30. One group
received an HB-MAS weekly when called to determine compliance and the other group
did not. The investigator analyzed the results of the MAS to have a better understanding
of the factors involved in noncompliance.
A quantitative method was used for the process of collecting, analyzing,
interpreting, and writing the results of this project (see Lamiani, Borghi, & Argentero,
2017). Quantitative researchers emphasize objective measurements, statistical,
mathematical, or numerical analysis of data collected through polls, questionnaires, and
surveys, or by manipulating pre-existing statistical data using computational techniques
(Bryman, 2017). For this project, the degrees of noncompliant patients were identified
11
from the responses to the questions from MAS. The MAS included five questions. For
each question, there is a scale of 1 to 4. The highest point a patient can earn is 4. The
quantitative method involves measurement, and a quantitative investigator assumes that
the phenomena can be measured. Quantitative investigations further set out to analyze
data for trends and relationships to verify the measurements made (Watson, 2015)
through comparisons of the results between those adhering and non-adhering individuals.
The primary objective of this project was to determine if an intervention, such as a
weekly phone call and the administration of an HB-MAS, could increase compliance in
the geriatric patient population by comparing the HB-MAS for each group.
Nature of the Project Design
A correlational comparative design was utilized with a focus on finding if
interventions, such as a weekly phone call, aids in increasing medication compliance and,
thereby, improves outcomes for the geriatric patient. This design was used to determine if
there was a relationship between the administration of weekly HB-MAS and medication
compliance. This design was also selected because it is widely used for testing the
relationship among variables. With the correlational design, the investigator can
determine if there is a relationship (see Mitchell, 1985) between noncompliance and
intervention, such as a weekly phone call.
The investigator used the quantitative correlational comparative design to analyze
the data and the variables to predict the existence of a relationship. With a project such as
medication noncompliance in the geriatric population, the probability value (p-value) was
used. A p-value of less than 0.05 indicated that significant differences exist between the
two groups: the participants of the weekly program and the nonparticipants. The analysis
of variance (ANOVA) was used, as described by Gorder and Foreman (2014), to
12
determine if the implementation of a weekly phone call will improve compliance among
the geriatric population.
Definition of Terms
For this DPI project, terms, variables, concepts, and phenomena were used. The
following terms and phrases were operationally used in this project:
Assumptions. Assumptions refer to something that is taken as certain or true to
happen without any proof (Simon & Goes, 2013).
Delimitations. Delimitations refer to limitations consciously set by the authors
themselves. They are concerned with the definitions that the researchers decided to set as
the boundaries or limits of their work so that the project’s aims and objectives do not
become impossible to achieve. (Theofanidis & Fountouki, 2018).
Dependent variables. Dependent variables refer to the variable of interest to the
researcher (Kaur, 2013).
Geriatric patients. These patients are 65 years of age or older (Rocque et al.,
2017).
Health literacy. Health literacy refers to the degree to which an individual can
obtain, communicate, process, and understand basic health information and services to
make proper health decisions (Rasu, Bawa, uminski, Snella, & Warady, 2015).
Independent variables. This variable is believed to affect the dependent variable
(Kaur, 2013).
Limitations. Limitations refer to any particular concern or potential weaknesses
of the project (Theofanidis & Fountouki, 2018).
13
Medication adherence. Medication adherence is defined as the extent to which a
person's behavior agrees with the agreed medication regimen from a health care provider
(Yap et al., 2016).
Medication adherence scale (MAS). MAS is an instrument that provides a
simple method for clinicians in various settings to assess patients' self-reported
compliance levels and to plan appropriate interventions (Kim, Hill, Bone, & Levine,
2000).
Medication compliance. This compliance refers to the extent to which patients
take medication as prescribed by their healthcare professionals (Verloo, Chiolero, Kiszio,
Kampel, & Santschi, 2017). Compliance was evaluated through the utilization of a MAS.
Medication noncompliance. Medication noncompliance is when medications are
not taken as prescribed (Jimmy & Jose, 2011).
Polypharmacy. Polypharmacy is characterized as the use of multiple medications
for the treatment of a single or several coexisting diseases (Bazargan et al., 2017).
Relationship status. Relationship status refers to an individual's connection with
a significant other (Alsabbagh et al., 2014).
Socioeconomic status. Socioeconomic status (SES) is a multidimensional
construct representing an individual’s position relative to other people in the community
(Alsabbagh et al., 2014).
Variables. Variables are comprised of anything that has quality or quantity that
varies in the project (Kaur, 2013). Two types of variables are used for this project: the
dependent variable and the independent variable.
14
Assumptions, Limitations, Delimitations
Assumptions. The patients participating in the project were contacted weekly,
and a MAS was administered with every patient contact. It was assumed that the
participants will answer the MAS truthfully. It was assumed that patients with one
chronic disease will be more compliant than patients with multiple chronic conditions. It
is also assumed that patients’ relationship status, socioeconomic status, and health
literacy can affect a patient’s compliance.
Limitations. The limitation of the project was that it was conducted at a center
that caring for patients of a specific culture and ethnicity. Most patients are African
American and are most are of Caribbean descent. The patients’ cultures may influence
their compliance with the treatment regimen. As stated by Bazargan et al. (2017), racial
differences in adherence to prescribed medication regimens among minority older adults
have been previously reported in several studies. It is suggested that factors that change
minority patients’ medication-taking practices must be re-examined. Another limitation
was that there were more women than men who participated participate in the project.
Delimitations. This project only focused on two clinical questions, which include
the following: (a) To what degree does the implementation of an HB-MAS via weekly
phone call increase medication compliance among the geriatric patient, and (b) what is
the relationship between the patients that are participating in the weekly an HB-MAS and
the patients that are not participating? This project was delimited to measuring the level
of compliance variable among geriatric patients. The data collected with the
15
implementation of the MAS and the weekly phone call was based on the guidelines set
for this project.
Summary and Organization of the Remainder of the Project
Nonadherence to prescribed medication is of major concern for the geriatric
population (Yap et al., 2016). Noncompliance with medication regimen may lead to
negative outcomes and or complications. Medication compliance can promote health,
decrease cost, and, in turn, increase life expectancy. Knowing the causes of
noncompliance with the geriatric population is a crucial step to understanding the issue of
noncompliance. Many patients are noncompliant with their medication regimen due to
ignorance of the effects of non-adherence or the expected sid effects of their medications.
The HBM is an ideal explanatory framework to address the issue of noncompliance, as
based on past researchers’ successful use of the model (see Baktash & Naji, 2019;
Becker, 1974; Luquis & Kensinger, 2019; Mirhoseni et al., 2019; Yazdanpanah et al.,
2019).
Numerous tools are being used to measure medication noncompliance, one of
which is the MAS. Although the MAS has been shown as helpful when dealing with the
issue of noncompliance, health care providers should produce guidelines to define
adherence procedures (Bercier & Maynard, 2015). Chapter two discusses an extensive
literature review on the previous body of works regarding the issue of noncompliance in
the geriatric population. The theoretical foundation of the project is presented in this
chapter, with emphasis on different learning behavioral and cognitive theories aiming at
increasing medication compliance. The focus in chapter two will also include evidence-
based practices and synthesis of the literature review.
16
Chapter 2: Literature Review
The number of people in the United States aged 65 years and over in 2010 was 40
million and is projected to rise to 88 million by 2050 (O’quin et al., 2015). Persistence in
medication adherence, especially among chronically ill seniors, is recognized globally as
a public health problem (Costa et al., 2015). Failure of chronically ill patients to adhere to
medication routines can worsen the symptoms and result in new complications.
According to Smith et al. (2017), medication adherence is abiding by the prescription
given for taking medication. However, Bazergan et al. (2017) stated that medication non-
adherence could occur in different ways, such as not filling the prescription, not taking
medication, missing doses, taking the wrong amount, taking medication at the wrong
time of day, not taking it as prescribed (e.g., with or without food), purposefully
discontinuing it for a period, or stopping it altogether.
Mcmullen et al. (2014) stated more than 50% of American adults use at least one
prescription drug; 10% take five or more of the prescribed drugs. Having multiple
prescription drugs that a patient is expected to take regularly can be burdensome, hence
making adherence difficult (Anglada-Martinez et al., 2015). Indeed, Anglada‐Martinez et
al. (2015), established that 50% to 60% of patients with chronic illness have a problem
with medication adherence. In as much as noncompliance is high among the chronically
ill, the effects are detrimental, resulting in 10% of all hospital stay and 125, 000 deaths
annually (Mayo & Mouton, 2017). The cost of hospitalization due to non-adherence is
$100 billion annually (Prayaga et al., 2018). Cutler et al. (2018) provided similar
findings, stating that the yearly cost of medication non-adherence in the United States
ranges from $100 to $290 billion.
17
To curb the negative effects of non-adherence among the geriatric population
more prone to multiple chronic illnesses, researchers should take advantage of mobile
technology. According to Prayaga et al. (2018), 70% of chronically ill senior citizens
believe that electronically requesting prescription refills is important. Due to the overall
increase of senior citizens with multiple chronic illnesses managed using different
medications (Verloo et al., 2017), there is a need to assess this alarming problem of
nonadherence among the geriatric population.
A systematic literature review was conducted through multiple online literature
sites using ProQuest, MEDLINE, PubMed, Cumulative Index of Nursing and Allied
Health Literature, Excerpta Medica Database, and PsycINFO to identify credible sources
for review. The search terms used included non-adherence, noncompliance, telehealth,
geriatric population, chronically ill, and phone call, and medication adherence scale. The
Boolean strategy was used, and some of the search terms were interchanged with their
synonyms to get more refined results. Additionally, limiters (including limiting articles to
those published within the last 5 years and only to peer-reviewed articles) were used to
ensure that the selected sources were up-to-date credible and meet criteria.
Medication adherence is highly important for any patient population; however,
the geriatric patient population requires a lot more attention regarding this subject matter.
According to Rubin (2019), nonadherence to medication can account for up to 50% of
failures in treatment in the United States. Additionally, it accounts for up to 25% of
hospitalizations in the same country. For this reason, 80% or more adherence patients are
required for optimal therapeutic efficacy. The older adult patient population is very
sensitive, considering that most have chronic conditions and are taking three or more
medications.
18
Medication adherence begins when the patients follow the recommendations
made by the healthcare provider (Frances, Thirumoorthy, & Kwan, 2016). Medication
adherence increases the chances of being treated appropriately, thus improving the state
of health of patients. Disease management takes precedence because the mortality rate is
decreased when medication adherence is achieved.
Healthcare providers must make it a priority to address compliance with their
geriatric patients to aid in decreasing complications (Frances et al., 2016). Various factors
have been identified to affect medication compliance in the geriatric, ranging from health
illiteracy, socioeconomic factors, cognitive illness, healthcare providers, and healthcare
systems. With the background identified, the goal of this DPI project was to improve
medication compliance and adherence in the geriatric population.
This chapter includes a discussion of the relevant literature based on themes
including the theoretical foundation. Next, statistics on non-adherence among chronically
ill geriatric patients are provided about the negative impacts. The theme of reasons for
non-adherence is then reviewed, followed using mobile phones in enhancing adherence.
Finally, the investigator presents the gaps in the literature that made it necessary to
conduct the current project.
Theoretical Foundations
19
Researchers and clinicians should think of health beyond it being only an issue of
the patient to face this challenging problem of non-adherence among geriatric patients
with chronic illnesses. One should also consider how it affects healthcare providers, the
government, family, and friends of the patient and the entire community (Siddiqui et al.,
2017). Non-adherence influences the entire healthcare system and the community in
general; hence, it should be handled holistically. Several nursing theories were
considered for this project, including self-care theory, the chronic care model (CCM), the
e-health enhanced chronic care model (eCCM), and the HBM; those models have been
applied in enhancing self-care and the overall health of chronically ill patients (Kwan,
2012; Sultan, 2016). The self-care model was unsuitable because researchers of the
model tended to presume that the patient was solely responsible for his or her self-care
and, therefore, unsuitable to the project. Given that the primary population for this project
is the geriatric patients who may have reduced functions due to their advanced ages, this
theory is rejected. Although the CCM and eCCM have some significant concepts that
would be relevant to the project, researchers of those models did not address the behavior
prediction. Thus, the HBM, which has been shown as a valid model for predicting health
behavior (C. L. Jones et al., 2016; Willis, 2018), will be the selected theory to be applied
for the project.
Researchers of the HBM have postulated that people take action to avert illness
(C. L. Jones et al., 2016; Willis, 2018)
1. If they believe that they are individually susceptible to a given condition
(apparent predisposition);
2. If they consider it to portend profound consequences (apparent severity);
20
3. If they believe that a certain course of action is at their disposal to help them
reduce the vulnerability, the severity, or result in other positive results
(apparent benefits); and
4. In case they believe that certain negative attributes are associated with the
course of action taken (apparent barriers).
Scholars have suggested that self-efficacy the confidence and conviction that an
individual can successfully finish the behavior or action of interest regardless of the
considered obstacles should be included as part of the model (Jones et al., 2016).
However, few studies utilizing HBM as a theoretical foundation have included self-
efficacy. Although it has been less examined, those who use the framework may posit
that certain cues (e.g., certain factors in an individual’s environment) can influence the
eventual course of action that a person takes. These cues to action can be either external
or internal and include factors, such as experiencing the symptoms of an illness and being
exposed to information related to medication and drugs for the said illness. Similar to
self-efficacy, the proposed cues to action have also been rarely investigated, especially
given the transitory nature (Jones et al., 2015).
Investigators have examined the viability of the HBM and its concepts regarding
behavior prediction; however, the findings of these studies have not been consistent
(Jones et al., 2016). The initial project analyzing the viability of HBM was carried out in
1974, and it focused primarily on assessing significant statistical associations instead of
looking at the impact of sizes (as cited in Jones et al., 2016). Jones et al. (2016)
established significant empirical support for HBM, with results from prospective studies
being almost as important as those from retrospective studies. Jones et al. found that
supposed barriers were the most significant single predictor, and supposed severity was
21
the least significant predictor of preemptive health behavior across all studies and
behaviors. Similarly, both supposed benefits and vulnerability were powerful predictors
of preventive health behavior; nevertheless, the perceived vulnerability was a stronger
predictor of protective health behavior.
On the contrary, other meta-analysis showed that the effect of each HBM
constructs on behavior was somewhat small (Carpenter, 2016). Nevertheless, these
studies were critiqued for not correcting the estimates of impact sizes of the unequal split
in behavioral result metrics, as well as the HBM construct measures. Regarding the
framework’s general effect, studies focusing on the predictive significance of the model
in its totality showed that HBM could indicate predictions of future behavior, although
somewhat weakly when compared to other health behavior theories (as cited in
Carpenter, 2016). However, most recent studies had shown that barriers and benefits are
consistently the most significant predictors. Overall, within Carpenter’s (2016) analysis,
the estimates were somewhat low for the associations between the estimates of how stark
a certain negative health finding would be for a subject and the possibility of the subject
adopting a given behavior. Furthermore, the association between vulnerability behavior
and beliefs was close to 0.
Carpenter (2016), Griffin (2017), and Patton et al. (2017) showed a conflict
occurred within the health belief literature. For example, health benefit constructs seemed
differentially linked to behavior, an outcome suggestive of a fundamental hierarchy for
the variables in the framework. Not only does this inhibit the progress of research, but it
also may explain the inconsistencies in the various reviews (Carpenter, 2016; Griffin,
2017; Patton et al., 2017). Regrettably, in many individual types of research, variable
ordering is not assessed, since HBM constructs tend to be examined considering their
22
additive effect on a result variable. For instance, various studies have shown that the
HBM constructs of perceived barrier, severity, and benefits were mutually powerful
predictors of medication acceptance. Other studies have also shown that perceived
benefits, vulnerability, barriers, severity, and self-efficiency were predictors of drug
adherence (Chao et al., 2016; Holmes et al., 2016).
Review of the Literature
The prevalence of non-adherence is shockingly high. The foundation of the
evidence for this project begins with a series of quantitative research literature reviews
and meta-analyses aiming at supporting the PICOT question relating to non-adherence
with the geriatric population. For instance, a meta-analysis conducted by Lemestra et al.
(2018) determined that only 29% of patients who have been hospitalized following a
heart attack fill their statin medication within 90 days as required. A quantitative study by
Miller (2016) that used a large cross-sectional sample of 75, 000 found that 30% of
patients did not refill their new prescription. This can be contrasted with findings from
Lee et al. (2018) that revealed 6% of senior patients had not adhered to their medication
for the last year.
Among non-institutionalized seniors, drug non-adherence ranges between 10 to
40%, resulting in a 10 percent increase in hospital admissions and 125,000 deaths. Non-
adherence complicates treatment and management of chronic disease (Nguyen, La Caze,
& Cottrell, 2016). Some patients may also be exposed to other health challenges if they
23
do not follow the prescription instructions. For instance, patients with HIV/Aids may be
at risk of contracting opportunistic infections.
Non-adherence to medication is no doubt a worldwide issue that should be
addressed immediately due to its detrimental effects such as increased cost of care,
increased comorbid diseases, worsening conditions, and even death (Chisholm-Burns &
Spivey 2012). According to Lemstra, Nwankwo, Bird, and Moraros (2018), in the United
States, non-adherence causes the country ~$290 billion (USD) yearly. Cutler et al. (2018)
recorded similar findings have been recorded, whereas Prayaga et al. (2018) recorded a
slightly lower cost of not less than $100 billion. In Canada, the cost of no-adherence is as
high as 1.6 billion Canadian dollars. Patients face the high cost of healthcare increasingly
each day. Chung, Marottoli, Cooney, and Rhee (2019) established that in 2017, 6.8% of
old adults (above 65 years) reported that they experienced the impact of non-adherence to
medication through the increasing cost of medications.
To combat non-adherence, collaboration from all stakeholders is necessary.
Families play an important role in providing support to clients when it comes to
medication adherence. Also, clients and family members expressed concern with
medication burden, which appeared to affect their support and adherence to medication.
Nevertheless, families considered medication to be an important component of treatment,
particularly because of the knowledge they gained from the intervention regarding the
illness (Balkrishnan 2005; Brown & Bussell 2011). It was found that families provide
ample support to patients when it comes to medication and believe it is important to
achieve health.
For instance, the probability of senior citizens who have no marital partner to
succumb to medication non-adherence is 56.7%, whereas the likelihood for patients who
24
have spouses is 47.8%. This implies that when there is a person who is close and shows
concern, then a patient is better able to adhere to their medication as opposed to when
they are all alone. El-Mallakh and Findlay (2015) stated that the support team should
offer all the necessary assistance for patients with neurological diseases such as
schizophrenia. Bolkan et al. (2013) conducted a longitudinal survey of 716 veterans and
found that due to family support and involvement, 71% of the veterans adhere to their
medication regiment—supporting the notion that those patients surrounded by the family
have better medication compliance.
Multiple reasons have been reported as barriers to noncompliance. The analysis
and synthesis of the literature review will continue based on two major themes: reasons
for noncompliance and emotional and physical fatigue as it relates to noncompliance.
Three subthemes will be associated with each of the themes. The three subthemes
identified as barriers to adherence are the high cost of medication, emotional and physical
fatigue, and communication. For Theme 2, utilization of mobile technology to enhance
adherence to the subthemes are accessibility and smartphone use to increase adherence to
medical prescriptions.
Barriers to adherence.
Poor adherence to medication is multifaceted. Understanding the reason for non-
adherence can aid in the formulation of interventional strategies to combat this issue.
Many aspects have been identified as a cause for non-adherence to medication regimen
such as emotional and physical fatigue, high cost of medication, communication,
demography, sociocultural, and behavioral, among others.
The high cost of medication.
25
Piette et al. (2011) described one of the major reasons for noncompliance as the
high cost of medication. Piette et al. stated that 2.7 million senior citizens accounted for
their non-adherence to medication as being cost-related. Lee et al. (2018) found that
medication un-affordability relates to non-adherence by (β = 0.55; standard error, 0.01; p
< .001). Most people did not refill their medications because of elevated costs. Senior
citizens are likely to be retired and have reduced functional skills; hence, they cannot
work as much as the younger generations (Piette et al., 2011).
Emotional and physical fatigue.
Emotional and physical fatigue brought about by taking medication can cause
non-adherence. Given that senior citizens are more prone to having more than one
chronic disease, each is managed by a plethora of different drugs. Often, patients must
take these medications regularly (Marcum et al., 2017). The side effects of the drugs can
be exhausting both mentally and psychologically, hence resulting in non-adherence.
Therefore, patients can simply refuse or forget to take the drugs, thus resulting in
medication wastage and increased cost of healthcare due to the wastage (Shruthi et al.,
2016). Physical exhaustion can occur if the patient must travel for the drug to be refilled.
The importance of eHealth and the use of mobile devices is that it can help patients
obtain drugs when needed.
In summary, the relationship that the patient has with their providers and
caregivers can influence commitment to medication prescription. Living on medication is
not easy, hence requiring much support in the form of education and encouragement by
the healthcare providers regarding medications. Caregivers should have an empathetic
relationship with their patients so that they can offer to encourage them to communicate
about their adherence (Midão et al., 2017). The caregivers should be well trained to take
26
care of the chronically ill patient, especially if they have a condition affecting their
mental health (El-Saifi et al., 2019).
Communication.
Communication is another barrier experienced in medication adherence.
Schoenthaler, Knafl, Fiscell, and Ogedegbe (2017) explored if healthcare providers and
patient communication played a role in medication adherence/compliance for
hypertensive patients. Schoenthaler et al. (2017) gathered information from a population
of 92 hypertensive patients. The data were collected through a patient-provider; all
encounters were audiotaped at baseline was used and coded using the Medical Interaction
Process System. The data were collected for 3 months regarding patients’ adherence.
This study was limited to patients with hypertension in primary care settings in
New York City, as more than 90% came from the New York region. The findings were
that the odds of poor medication adherence are greater when patient-provider interactions
are low in patient-centeredness and do not address patients’ socio-demographic
circumstances or their medication regimen (Schoenthaler et al., 2017). Lack of adherence
has resulted in high rates of morbidity and, in some cases, has resulted in deaths.
Researchers have reported that most patients who do not adhere to their prescribed
medication regimens lack knowledge on the importance of medication (Schoenthaler et
al., 2017). Therefore, communication and education of the public on the importance of
prescribed medication in treatment plans is of the utmost importance to ensure good
health.
There are various causes of noncompliance with medication. According to
Hugtenburg et al. (2013) and Fischer et al. (2010), some of the causes include fear of
potential side effects, misunderstandings of the prescriptions, depression, and mistrust of
27
the medication and lack of symptoms, among others. Before any intervention to the
issues of noncompliance is considered, there is a need to understand the underlying
causes of non-adherence. Based on the literature reviewed, the causes of non-adherence
can be put in several categories, such as social and economic aspects; factors related to
medication, patient-related aspects, and health care system issues; and finally, the issues
related to the condition in which a patient is suffering. By understanding the cause of
noncompliance to drug administration, a good policy to ensure compliance can be well
designed, such as the National Public Health Policy in Sweden (Wamala et al., 2007).
There is a need to measure noncompliance to medication as researchers and
clinicians can then use results to design tailor-made intervention mechanisms. Ineffective
methods of countering the problem of non-adherence can result in undesirable outcomes
(Wamala et al., 2007). Undesirable outcomes are costly and dangerous to the patient’s
health and should be avoided at all costs by ensuring that each cause of noncompliance is
well articulated by the patient and dealt with accordingly. Inaccurate methods of
intervening in the issue of noncompliance due to lack of communication may result in the
rejection of a highly effective method of intervention by the patient.
In summary, providers need to assess and evaluate the causes of noncompliance. One
must realize that adherence to a medication regimen is a multidimensional occurrence.
Healthcare providers need to communicate with their patients and assess their
understanding of their medication regimen. The stress of taking multiple medications can
become overwhelming and causes patients to be in distress emotionally.
Utilization of mobile technology to enhance adherence.
According to Braun et al. (2013), the concept of mobile technology is the type of
technology using cellular communication. Healthcare providers can use technology to
28
provide care and monitor patients at a distance. Technology has many uses in medicine,
evolving and changing the dimensions of the delivery of care. The accessibility factor
makes a significant impact on health care. The use of technology in health care aid with
patient monitoring, decrease unnecessary office visits, and decrease hospitalizations, as
further described by Braun et al. (2013).
Accessibility.
Providers can call patients using their mobile phones to check if patients have
any questions or problems. In a study by Lyons et al. (2016), patients with chronic illness
were enrolled in a program with access to two telephone conversations after 1 month or 6
weeks where they talked to a pharmacist. After 6 months, the findings showed that those
who had the telephone conversation had an adherence rate of at least 90%, whereas those
in the control group had an adherence rate of 19.6%. These findings indicated that having
a telephone conversation with a chronically ill patient could significantly increase their
chances of adherence. However, the content of the telephone conversations did not
necessarily focus on adherence, but the conversations were tailored to the individual
needs of the patient (Turner et al., 2016). Having patient-centered care should be the goal,
even when the use of mobile phones is introduced. The provider should have the etiquette
required when asking the patient about their personal information (Haase et al., 2017).
Calling patients is an expression of care. Central to the role of nursing is patient
care, which should be pursued through all possible means (Delaney, 2018). Providers can
partner with their patients and build a professional relationship to enhance care using
mobile phone conversations. To ensure the objectivity of the conversation, the provider
should have a guide. Delaney (2018) suggested the MAS be used so that the conversation
would be focused on adherence. Objectivity enhances respect and ensures that the right
29
boundary is set to enhance a professional relationship between the provider and the
patient (Steele et al., 2016). Providers should support patients, especially those patients at
risk of psychological issues, such as stress from their conditions. Such care ensures that
the patients have follow-ups and reminders to remain committed to taking medications as
prescribed, as opined by Watkins et al. (2018).
Cellular phones are already accessible in the United States. The rapid penetration
of devices has transformed the population of the United States, such that even the seniors
have smartphones (Watkins et al., 2018). Indeed, up to 59% of people aged 65 to 69 years
have smartphones; the percentage of smartphone owners for those in the age bracket of
70 to 74 is 49% (Subramanyam et al., 2018). Besides, those who do not have wireless
phones have landlines and other analog phones, which can still be used for conversations
regarding their health (Boulos et al., 2011). The importance of smartphones and other
wireless phones is that phones are portable; therefore, the owners can be found easily
through a phone call. The availability of mobile phones, which provide accessibly to the
patients, will aid in the successful implementation and completion of the DPI project,
given that the patients will only have to use their preferred phones at the time of calling.
Smartphone use to increase medication adherence.
In the United States, more than half of adults over 65 years old take at least three
to four medications daily to treat chronic conditions and age-related changes in physical
and emotional health (Sanders, 2013). Park, Howeie-Esqivel, and Dracup (2014)
conducted a systematic quantitative review without meta-analysis for prevention
purposes, as well as the management of acute and chronic illnesses. The researchers
found that the use of text messaging would significantly improve medication adherence.
Data collection consisted of a literature search of 29 quantitative research studies related
30
to mobile phones and medication adherence. Although there was a significant
improvement in medication adherence, it was suggested that long-term studies
characterized by rigorous research methodologies, appropriate statistical and economic
analyses, and the test of theory-based interventions are needed to determine the efficacy
of mobile phones to influence medication adherence (Park et al., 2014).
Individual patients can use invented applications (apps) to improve their practices
of adhering to medical prescriptions—the other reason that using smartphones may
increase adherence to medication (Morrissey et al., 2018). Inventors create apps to
enhance self-management for patients facing chronic conditions. Morrissey et al. (2018)
showed that increasing patients, including older adults, have embraced the use of
smartphones to improve their health statuses. Choi et al. (2015) also pointed out the
benefits of using smartphones in increasing adherence to medication. The researchers
identified 160 adherence applications, which were integrated into smartphones. Their
findings showed that irrespective of the untested nature of the majority of the apps, they
represented a possible strategy recommendable by healthcare providers to patients who
are non-adherent to improve their ability to observe medication (Choi et al., 2015). For
this research study, the use of the phones is an added advantage to the targeted patients
given their high potential of increasing adherence to medication.
To summarize, phone intervention for medical care is a rapidly evolving practice
that has been utilized to improve the delivery of health services in many jurisdictions
across the world (Free et al., 2017). The use of the phone can be a low-cost solution to
offering health education and improving medication compliance for people with chronic
diseases. For instance, Kim and Jeong (2017) studied mobile phone SMS use by nurses in
South Korea and found that for 6 straight months, the use of SMS reduced HbA1C in
31
patients with diabetes to about 1.15% at 3 months and about 1.05% at 6 months, which
was somewhat better when compared to the baseline in the control group. Similarly,
Horvath, Ill, and Milánkovich (2017) also demonstrated that phones were effective tools
for offering health education, medication and clinic appointment reminders for chronic
diseases, such as HIV and diabetes, as well as for building awareness regarding diseases.
Recent research in the Netherlands showed that mobile phones improved compliance to
medication by Type II diabetes patients, particularly regarding the precision with which
the patients adhered to the regimen prescribed; additionally, they accepted it as an
essential intervention tool for medication compliance (Vervloet et al., 2018).
Summary
Medication adherence, especially among seniors (people aged 65 years and
above), is poor. Yet, this population has an increased risk of getting multiple chronic
diseases compared to younger people. Nonadherence has negative impacts ranging from
increased hospitalization and deaths, proneness to opportunistic diseases and worsening
of symptoms, and elevated costs of treatment. Given that the population throughout the
globe is aging, the issue of non-adherence is a major concern that should be addressed.
Many theories have been applied in handling the issue of non-adherence, the
investigator has found the HBM as the most effective. Theorists have postulated that
messages will achieve optimal behavior change if they successfully target perceived
barriers, benefits, and self-efficacy (C. L. Jones et al., 2016), thus finding the barriers to
noncompliance can help increase compliance through discussion, clarification, and
patient education.
Several factors can negatively affect compliance with medication. Such factors
can be economical, making acquiring the medication unaffordable. Another factor is
32
emotional fatigue resulting from taking many drugs almost daily, dealing with the side
effects of those drugs, and lack of supportive relationships. A weekly call and completing
a MAS exude caring, concern, empathy, and support.
It is expected that the group with the intervention will show a significant change
in that their rates of adherence which will lead to positive health outcomes. The next
chapter will be the methodology section. Chapter three contains detailed information
about the methods and designs used in identifying and selecting the sample, collecting
data, and analyzing the content provided.
33
Chapter 3: Methodology
Older adults have chronic diseases and multiple comorbidities. Adherence to
medication is essential in achieving therapeutic levels, which is beneficial in disease
management (Frances et al., 2016). Nevertheless, medication compliance has been an
issue, particularly amongst the geriatric population. Medication adherence (i.e.,
medication compliance) is a complex and important component of caring for older adults.
Many research studies about noncompliance with prescription medication have occurred
among geriatric patients. Although qualitative, quantitative, and mixed-method
approaches have been utilized to discuss this global problem, most researchers utilized
quantitative approaches. Quantitative researchers present the findings numerically and
ensure generalization of findings to a wider population.
For this project, the quantitative correlational method was to answer the following
questions:
Q1: To what degree does the implementation of a medication adherence scale via
weekly phone call increase medication compliance among geriatric patients with
chronic diseases?
Q2: What is the relationship between the patients who are participating in the
weekly MAS and the patients that are not participating?
This chapter includes the details about the methodology that was used to get the
relevant data for the project. It discusses the project’s methodology, project design,
population and sample, instrumentation, validity and reliability, data collection
procedures, data analysis procedures, ethical considerations, and limitations of the
project. Emphasis was placed on documenting the processes involved in conducting this
project in detail to facilitate replication by others.
34
Statement of the Problem
The problem with non-adherence is that it increases the chances of prolonged
hospitalization, worsening of symptoms, and possibly even causing death. Specifically,
lack of adherence causes nearly 125,000 deaths, causes 10% of hospitalizations, and costs
the already strained healthcare system between 100 to 289 billion dollars a year (Mayo &
Mouton, 2017). Miller (2016) attempted to find answers and provide recommendations to
assist with the problem of non-adherence among the chronically ill seniors. His cross-
sectional study of a large sample of 75,000, establish that 30% of people with chronic
illness did not refill their prescriptions; diabetes and high cholesterol were not filled 20%
to 22% of the time, respectively (Miller, 2016). According to Bazargan (2017), cultural
factors are among the causes for non-adherence; the study showed that an average of
5.7% of African-Americans aged 65 years or more did not know the purpose of at least
one of their medications over 56% of the time. Additionally, non-adherence results in a
high cost of treatment for both the individual patient and the healthcare system (Mayo &
Mouton, 2017).
Healthcare providers and patients should work together to formulate
individualized plans to arrive at compliance. Uses of information technology in
healthcare, such as mobile applications, have been shown as useful in enhancing
adherence. However, it was not known if the implementation of a MAS through a weekly
phone call from the interdisciplinary team to noncompliant patients can increase
compliance with the medication regimen at the clinic. This DPI project showed new
findings relevant to resolving the problem.
35
Clinical Questions
Restating the clinical questions provides a basis for understanding the design
adopted in strategizing processes to increase compliance among the geriatric population,
which is crucial for healthcare providers to aid geriatric patients at being compliant.
Identifying strategies that can influence medication compliance in geriatric patients can
significantly decrease the rate of negative outcomes related to poor compliance in the
geriatric population.
It is not known how to increase medication compliance by providers amongst the
geriatric patients. The PICOT question to be answered is the following: (P) With geriatric
patients with chronic illnesses who are noncompliant with their medication regimen, (I),
how does the implementation of of a weekly phone call and the administration of an HB-
MAS (O) improve compliance (C) comparing to those who do not participate (T) over a
period of six weeks?.
The specific clinical questions are as follows:
Q1: To what degree does the implementation of an HB-MAS via weekly phone
call increase medication compliance among geriatric patients with chronic diseases? The
MAS is a scale used to evaluate the degree of adherence to medications. The MAS was
originally developed in 2000 by Myong Kim, Martha Hill Lee Bone, and David Levine.
This scale was used to measure medication adherence for hypertensive patients. Since
then, it has been used for several chronic diseases. The MAS for this DPI project was
used as a tool for screening geriatric patients for medication adherence.
The first clinical question was to determine if there is a relationship between the
MAS and the increase in medication compliance. The weekly MAS performed via phone
call will be the independent variable, while an increase in compliance rate with
36
medication regimen among geriatric patients is the dependent variable. The second
question is the following:
Q2: What is the relationship between the patients who are participating in the
weekly MAS and the patients who are not participating? The second clinical
question focused on examining if there is a relationship between the patients
participating in the weekly MAS and the patients who are not participating. The
independent variable was the relationship between patients who are participating
in the weekly MAS. The dependent variable was the outcome of participation.
Project Methodology
Three basic methods of conducting projects include quantitative, qualitative, and
mixed-method designs. Qualitative projects are often used for exploring phenomena that
deal with the question of “why” and “how” of the problem statement. The investigator’s
focus when conducting qualitative projects is to explore the similarities and patterns in
the dataset (Brannen, 2017). Conversely, the investigator can use quantitative projects to
show the relationship between the dependent and the independent variables. The method
is ideal in problems requiring future predictions to develop an understanding of the
degree to which one variable impacts the others.
With most projects, the investigator starts with identifying variables and then
forming the project questions to be tested (Rivera et al., 2017). The mixed-method
investigator combines both the qualitative and quantitative methodology in the same
project (Halcomb & Hickman 2015). For this project, a quantitative methodology was
utilized. Quantitative methodology is often objective as it employs randomization in the
sampling procedure and uses a big sample. The results obtained can be generalized to a
wider population. The use of quantitative methodology is most appropriate given the
37
nature of the PICOT question, which involves predicting future outcomes for using
weekly MASs to enhance compliance.
Project Design
The project’s design was specific to a strategic method of collection and analysis
of data. The focus of the project is on the objectives to be achieved, as well as how the
presented project’s problems are tackled to evaluate pre-and post-intervention outcomes.
In essence, the design was concerned with the operation patterns in the project, such as
the kind of information to be collected, the sources of obtaining such information, and the
specific procedures needed (Hicks, 2009). The project design is extremely important.
Adopting the correct design ensures that the information will show all the concerns raised
in the research questions (Lamiani, Borghi, & Argentero, 2017).
A correlational comparative design was deemed as most appropriate for this
project because the investigator has an interest in the absence or presence of a predictor
relationship between use of the weekly MAS and level of compliance among chronically
ill geriatric patients. According to Foot et al. (2016), the correlational design is most
proper in project questions seeking to analyze the predictive relationship. With this
design, it is more effective to study the scores in a group as opposed to individual scores;
the investigator keeps the group variable discrete to retain the highest power in the
statistical result. Investigators can use correlational designs to discover relational trends
(assessing the positive and the negative variables) within a single group (Lamiani et al.,
2017).
According to Rivera et al. (2017), project investigators should have a large range
of variables scores to determine the existence of the relationship. With this project, the
main variables include weekly MAS through phone calls (independent) and increased
38
compliance rate with medication regime among geriatric patients (dependent). Other
variables that were not the focus of this project but might have influenced the outcome
would include the sample’s ethnic background, level of education, marital status,
socioeconomic status, and health literacy.
One of the techniques commonly used to collect data in correlational design is
survey questionnaires. For the project, the MAS served as a survey questionnaire and was
utilized in the data collection process. Participants were asked to respond to the MAS
truthfully about their compliance with their medication regimes.
Population and Sample Selection
39
The population of interest for the project included geriatric patients with chronic
illnesses, specifically those who self-report noncompliant with medication regimens in a
clinic located in the southeastern part of the United States. For this reason, the
investigator applied the following inclusion and exclusion criteria: (a) patients 65 to 82
years of ages and above; (b) patients with at least one chronic illness for which a
prescribed medication has been provided, (c) patients are not hospitalized, (d) patients
self-admit noncompliance with their prescription medications, (e) patients who are not
cognitively impaired, and (f) patients with an operational phone. The exclusion criteria
involved exempting patients below the age of 65 who are compliant with a medication
regimen, have no chronic illness, are hospitalized at the time of the study, or are
cognitively impaired, and do not have access to a phone. For the sample, the investigator
identified a total of 60 patients who are between the ages of 65 to 82 and self-admit
noncompliance. They were divided into two groups; one group received a phone call
weekly and an administration of a MAS while the other did not.
A convenience sample was used in getting the sample as it has the advantage of
allowing the investigator to obtain relevant basic data as well as trends regarding studies
as opposed to the use of a randomized approach (Li & Haupt 2016). The procedure for
undertaking this sampling method involved first taking multiple samples from the
population an approach meant to produce reliable results. Secondly, the process of
surveying the population was repeated to understand whether the results are truly
representative of the population identified chronically ill geriatric patients. The third and
final stage involved cross-validation of the data, followed by comparison with the other
section of the general population. Selecting the desired sample to reduce bias and
facilitate the repetition element process (Etikan, Musa, & Alkassim, 2016). The patients
40
were divided into three strata based on their number of chronic diseases. The first strata
comprised of patients diagnosed with one chronic illness. The second strata were for
patients with two chronic illnesses, while the third strata were for patients with more than
two chronic illnesses. The investigator then performed a convenience sampling for each
of the strata.
This sampling strategy was selected because of its objectiveness. Other
advantages of using convenience sampling include enabling the investigator to get a
separate effect size from each of the strata and ensuring that even the minority samples
are included in the study to get representatives from all populations, especially when the
process is repeated (Ponto, 2015).
The total sample obtained for the study will include 30 participants. This sample
was convenient for the investigator as it helped in writing a program for administering the
MAS.
In calculating the right sample size, the general formula is the following:
n=2(Zα+Z1− β)
2 σ 2
∆2
In the equation, n is the sample size required, and were 30, Zα, Z are constants with
regards to accepted α . On the other hand, the Z1-, β, Z are also representative of
constants reliant on the power of the study. The σ is the standard deviation, while ∆
refers to the difference in the effect of two interventions (Kadam & Bhalerao 2010). The
calculation of the sample size is as follows:
n=2(0.123+0.0 .369)2(0.492)2
0.252 = 30
The investigator predicted the following two potential outcomes of the study:
41
H1: There is a strong relationship between the implementation of weekly phone
calls and the administration of a Medication Adherence Scale and medication
compliance of the geriatric patients.
H2: There is a statistically significant difference in medication compliance levels
between the chronically ill geriatric patients who participate in the weekly phone
calls and the administration of a medication adherence scale and those who do
not.
Instrumentation or Sources of Data
The tool used for data collection will be the HB-MAS with five questions; it was
approximated to take, at most, four minutes. The questions’ responses will be 1, 2, 3, or
4, assigned respectively, which translated to the highest possible of 20 and the lowest of
5. The interventional group n=30 received a phone call and completed the HB-MAS
weekly. A high scoring scale is indicative of less adherence while a low score indicates
more adherence to the prescribed medication regimen. The pre and post-HB-MAS scores
for the comparison and the interventional groups were compared and analyzed. However,
it was predicted that the comparison of the HB-MAS for both groups will show an
increase in compliance rates of all participants enrolled in the weekly phone calls and the
administration of an HB-MAS program. Given the sample for the current study, the
administration of the HB-MAS via phone interviews was cost-effective compared to face
to face, which will incur transportation costs and be time-consuming (see Ponto, 2015).
The questions of the HB-MAS were brief and concise, uses a variety of questions
that were easy to administer. This was ideal, given that the target population comprised of
geriatric patients who may tire quickly. Questionnaires often show high levels of internal
42
consistency and validity, which can ensure that the actual variables of the study are,
measured (Van den Broucke et al., 2011).
Validity
Validity refers to the degree to which evidence in a project measures what they
claim to measure (Althubaiti et al., 2016). In the current project, criterion-related,
content, and construct validity of the questionnaire will be established. The content
validity indicates the extent to which the items included in the questionnaire and the
scores of each question represented all possible questions about the improvement of the
compliance rate among chronically ill geriatric patients. The key concept of
administering a MAS through phone calls and chronic diseases noncompliance was
compared with other related studies to identify similarities in the findings. The reliability
and validity of the MAS tool are because it is easy to implement and can be adjusted as
necessary (Ueno et al. 2018).
According to Provost et al. (2015), validity is discriminant and convergent.
Discriminant validity shows how items operate in the same way converge with like items
and diverging while discriminating against opposites. Conversely, convergent validity
refers to how several variables associate positively in a similar direction; higher
convergences have more similarities in operations. The goal was to establish valid
scientific outcomes; hence, the questionnaire was adjusted to achieve accuracy and
credibility.
Reliability
Reliability is the extent of the consistency and reproducibility of the study
(Leung, 2015). The participants were randomly split into two halves. The results for each
set were analyzed to ensure that the research instrument is reliable. This process showed
43
high similarities between the split-halves, which is indicative of the instrument's high
level of reliability. Reliability is significant during the assessment, as it is often presented
as contributing to the overall validity of the study. Additionally, reliability is the extent to
which a tool gives measurements that are consistent, stable, and repeatable (Kelly,
Fitzsimons & Baker, 2016). For the project, all the questions were clear and free of error.
The questions from this tool ensured that measured specific variables and were easily
assigned a numerical variable, which eased the analysis process. Utilizing the Rasch
Analysis Index will enable examination of whether replication of items in the same order
is possible given a different sample with similar characteristics (Chang et al., 2014). The
Rasch analysis model was used to point out negatively worded items, leading items,
redundant items, and those out of the concept, thus not having any valid contribution to
the research questions. The items of the final instrument contained questions relevant to
the project and they are free of errors contributing to a high level of reliability.
Data Collection Procedures
The data collection procedure was a significant step in the project process as it
involves the practical steps taken to gather information from the participants (Li et al.,
2015). According to Li et al. (2015), data collection procedures should outline the
systematic steps used to arrive at the evidence for the project question. Several
procedures and methods that can be used in data collection include case studies, historical
methods, descriptive methods, and experimental methods. For this project, a combined
aspect of survey and experimental procedures used in obtaining the data.
At the beginning of the project, the delivery of participant’s medications was
confirmed with the pharmacy. Participants were required to bring their medications for
reconciliation and confirmation before the start of the project. It was confirmed that all
44
participants had the right medication and the right amount of medication to cover the
whole 6 weeks of the project. Furthermore, for this project, the participants were
approaches on days that were not too busy, and when the target populations had group
therapies to get as many people as possible. The investigator, with the assistance of the
clinic’s employees, introduced herself as a doctorate student conducting a project on how
weekly phone calls and the administration of an HB-MAS can enhance medication
compliance among the chronically ill geriatric patients. The relevance of the project was
explained to the patients, healthcare providers at the clinic, as well as the assistant. They
were also made aware of the duration of the project, and the need for a phone number for
contact purposes.
An HB-MAS was collected from all 60 participants at the beginning of the
project. The completed HB-MASs were stored in a locked drawer to prevent
unauthorized events. Over the consecutive 6 weeks, a phone call was placed and an HB-
MAS was completed for one group each week. Participants must have been contacted for
all six weeks to be eligible. At the end of the 6 weeks, an HB-MAS was again
administered to all 60 participants. The data for both groups were then compared to
analyze the degree of compliance. Clinical values were also compared and examined.
The MAS was securely stored in a locked drawer in an office with a locked door to avoid
interference from unauthorized individuals in preparation for the data analysis process.
The entire data collection process took a period of 7 weeks; 6 weeks mainly used for the
MAS administration. The data was then transferred to Statistical Package for the Social
Sciences software (SPSS) for calculation.
The variables being assessed include the following:
The independent variable included the implementation of weekly phone calls
45
and the administration of a MAS through a phone call to establish patients’
adherence to medical prescriptions.
The main dependent variable included the level of adherence to medical
prescriptions.
The other dependent variable included the number of chronic diseases,
age, gender, educational level, socioeconomic level, and relationship
status, as they are also related to medical prescription adherence.
Data Analysis Procedures
Given the nature of the project as a quantitative study, statistical and
mathematical procedures were used to analyze the data. The characteristics and
demographic features of the participants involved using descriptive analyses. As
suggested by the name, descriptive statistics often yield findings in terms of the standard
deviation (absolute dispersion), means (arithmetic mean), correlational coefficient,
percentages, and frequencies, which are relevant in understanding the scope of
participants. The descriptive statistics also enhance the process of discussing the results.
The descriptive statistic process was used for measures of variation and dispersion. The
collected data was then transferred to a Statistical package for the social sciences (SPSS)
the process of calculation, and open-refining.
Given the nature of the project as correlative, the Pearson correlation coefficient
“r” (product-moment correlation coefficient) was utilized in the analyses. The clinical
questions included the following: (a) What is the relationship between the patients that
are participating in the weekly phone calls and the administration of a medication
adherence scale program and the patients who are not participating, and (b) to what
degree does the implementation of weekly phone calls and the administration of a MAS
46
via a phone call increase medication compliance among the geriatric patient?
Responding to the first question involved comparing general assumptions
concerning the findings from the participants. The response to the second question
involved analyzing the effect of the use of a phone call and MAS in improving
compliance with the medication regimen. The first assumption to be considered is the
following: There is a strong relationship between the implementation of MAS via weekly
phone calls and medication compliance of the geriatric patients. The second assumption
is the following: There is a statistically significant difference in medication compliance
level between the chronically ill geriatric patients who participate in an HB-MAS
program and those who did not.
The Pearson correlation model is proper when the variables are normally
distributed because the coefficient is often affected by values that are extreme, leading to
an exaggerated of dampened result (Yang et al., 2016). According to Pandis (2016), the
Pearson correlation coefficient is effective in expressing the strength of how two
variables correlate within a linear relationship; the values often range from -1 to 1. A
positive correlation is determined if findings show that high values in one variable rate
with high values of the others. In this case, a positive correlation can be evident because
the progressive use of weekly phone calls and an HB-MAS can be associated with higher
rates of medication compliance for the group.
A hierarchical multiple regression analysis was used to test the other variables
that may have influenced the outcome of the findings for both assumptions. Other
variables were measured using the hierarchical regression analysis which includes age,
gender, educational level, and numbers of chronic disease characteristics. The reason for
including hierarchical regression is due to findings of other investigators suggesting that
47
such factors can affect adherence to medical prescriptions (Yap et al., 2016). The SPSS
was utilized in both of the statistical calculations to determine correlation, and the
recommended p-value was ≤ 0.05.
Ethical Considerations
Ethics is concerned with the conduct of peoples, hence provides guidelines for
standards and norms that are acceptable when interacting with others (Ellis-Barton,
2016). Therefore, investigators should abide by the Institutional Review Board (IRB)
guidelines. The IRB guidelines are aimed to protect participants from physical,
emotional, psychological, monetary, and legal issues that may arise when research studies
are conducted in ways that are inconsistent with the required guidelines (Yip et al., 2016).
In some cases, ethical issues may be related to the research process. Before the data
collection process, IRB approval, permission to utilize the evidence-based tool, and
permission to conduct the project were given by the administration of the clinic to
conduct the project at the site.
Privacy, anonymity, and confidentiality were maintained throughout the whole
process. Participants were recruited privately in a comfortable environment and all of
their questions were answered. Privacy was also maintained and ensured during the
administration of the MASs. Additionally, all the data collected were stored in a secure
place to prevent any unauthorized access. They were securely placed in a locked drawer
behind a locked office door accessible only by the investigator.
Confidentiality and anonymity were ensured by assigning numeric code to each
participant. The utilization of the codes helps ensure specific information is not traceable
to specific respondents. Participants were not required to provide any personal
48
information in the instruments which ensure a high degree of anonymity. Furthermore,
data analysis did not involve the names of participants nor the project site.
To reduce any bias guidelines and the role of each participant were clearly stated
at the start of the project. Additionally, it was made clear to those participating at the
beginning of the project that there will not be any forms of material or monetary rewards
for their participation. The participants were also made aware that they were at liberty to
ask any question for further clarification before agreeing to participate. Only those who
consented took part in the study. Furthermore, it was communicated to the participants
that as much as their participation during the entire time of the project was highly
desired; they were at liberty to stop their participation at any time if they choose to and
for whatever reason without fear of any consequences.
The results of the project will be shared with the colleagues at the clinic to
encourage the use of evidence-based information for dealing with chronically ill geriatric
patients who are not adhering to their medication regimen. The project was beneficial to
all parties involved, which includes the participants, the facility, and the investigator.
Throughout the process of conducting this project, there was minimal if any harm
incurred by either the investigator or the participants.
Limitations
According to Theofanidis and Fountouki (2018), the limitations of a project refer
to any particular weaknesses usually out of the researcher’s control and are closely
associated with the chosen research design, statistical model constraints, funding
constraints, or other factors of the characteristics attached to the design or the
methodology that affects the findings and their interpretation. Limitations often provide
constraints on generalizability, practical applications, and other utilization of the findings.
49
There is no absolute perfect project because there are various loopholes that can
compromise the integrity of the study. However, these loopholes can be addressed with
keen consideration. One of the limitations of this project was that for participation to be
possible, the respondents needed to have a phone. Although a large number of geriatric
patients had access to a phone, a few participants who are qualified and willing to take
part in the project were not able to participate due to a lack of access to a phone. Given
that the population of interest is of geriatric who, unlike the young generation, have lower
chances of having a phone, a few were excluded. Additionally, patients who become
hospitalized during the project would have had to drop out of the study. Fortunately, none
were hospitalized during the project.
The other limitation of the study was that the sample used was not representative
of the entire population as one of the characteristics of MAS (Lam & Fresco, 2015). All
the participants will be sampled from within the same clinic, which caters to a specific
culture, thereby implying that generalization of an older adult is not entirely appropriate.
This process will also be a limiting factor as it will gradually reduce the sample size.
Based on the sample, the study may not be representative of patients from all
socioeconomic backgrounds and ethnicities.
Summary
Issues of noncompliance to prescribed medication among geriatric patients with
chronic illnesses are common (Mayo & Mouton, 2017). Yet, the consequences of not
following the medication have detrimental effects on both the individual patient and the
healthcare system. Resultantly, there is a need for providers to adopt new strategies to
collaborate with geriatric patients so that they can improve on how they comply with the
drugs. The weekly phone calls and MAS provide the potential for such collaboration;
50
however, there is a paucity of studies that have explored this possibility. The project was
an attempt to fill this research gap by investigating the correlation between weekly phone
calls and the level of adherence. a quantitative correlational design was to examine how
to increase medication compliance by providers among geriatric patients. The data was
collected in a local clinic with a total of 60 respondents selected following stratified
random sampling. The project took place within six weeks, where the MAS was
administered to one group of the respondents. HB-MAS was given to collect data at the
beginning of the program. At the end of the six weeks, an HB-MAS was administered for
comparison and clinical values were examined. The collected data were statistically
analyzed. This project had a few limitations. Ethical considerations were considered, for
the protection of both the participants and the investigator. A discussion of the data
collected and the analysis using simple descriptive is statistics are discussed.
51
Chapter 4: Data Analysis and Results
Medication compliance is an essential part of the treatment plan. However, 50%
or more of patients with chronic diseases do not take their medications as prescribed.
(Sanders & Van Oss, 2018). In the geriatric population, nonadherence increases with
multimorbidity, polypharmacy, regimen complexity, previous adverse drug events
(ADEs), and impaired cognition (Siu et al.2019). According to Costa et al., (2015),
medication adherence is recognized as a worldwide public health problem, particularly
important in the management of chronic diseases. Aging puts the geriatric patient at risk
for chronic diseases. Proper usage of medications and compliance to medications has
been associated with improved health, increased functional status, decreased risk of falls,
improved cognition (Sanders & Van Oss, 2018).
The purpose of the project is to evaluate if an intervention such as a weekly phone
call and the administration of a medication adherence scale (MAS) can help providers to
evaluate and improve medication compliance amongst the geriatric population. Although
there have been many studies regarding noncompliance with medication regimen, it
remains a worldwide problem, especially concerning the geriatric population. To tackle
this issue, this DPI aimed at investigating contributing factors to medication
noncompliance and is geared towards finding possible ways to assist healthcare providers
in increasing compliance through planning and applying effective tailored care. This
project intended to answer the following clinical questions: Q1: To what degree does a
weekly phone call and the administration of MAS increase compliance in geriatric
patients over a period of six weeks? And Q2: What was the relationship between a
weekly phone call and the increase in medication compliance in geriatric patients? A
quantitative methodology and MAS were used to answer those questions. This chapter
52
discusses data collection and analysis including procedures and results.
Descriptive Data
Descriptive data analysis was performed to evaluate the general and clinical
characteristics of the participants. There were numerous statistical techniques used to
analyze the data. The population is geriatric patients between the ages of 65 to 82 years
old who were patients in a private clinic in the Southern part of the United States. The
participants must have had at least one chronic condition, admitted noncompliance with
their medication regimen, had no impaired cognition and had access to a phone. For the
project, there were a total of 60 patients who admitted noncompliance with their
medication regimens. The participants were divided into two even groups of 30. One half
received a weekly call and complete MAS and the other half had no intervention of any
kind. General and clinical characteristics were used to evaluate the data. All of the
participants were be above 65 years old. Forty-eight participants suffered from
hypertension, 12 with diabetes, and 33 suffered both diabetes and hypertension. There
were 19 males and 41 females (see Figure 1). There were 18 participants with one
chronic disease, 20 with two chronic diseases, and 22 with more than two chronic
diseases (see Figure 2). Forty-six participants were between 65 to 75 years of age and
fourteen were between the ages of 76 to 82 years old (see Figure 3). Forty-seven
participants were high school graduates, while 13 participants went to college (see Figure
4).
The project involved a total of 60 pre-test participants. A total of 30 participants
was assigned to the non-intervention group while the other 30 participants were assigned
to the interventional group. The 30 intervention participants were the participants who
received a weekly phone call and complete the MAS. Among the 30 patients in the
53
intervention group that received a call (N = 30), 10 (33%) participants had Hypertension
(HTN), 8 (27% ) were with type 2 diabetes (DM), 3 (1%) with DM, HTN and
hyperlipidemia, and 1(3.%) with DM, HTN, and 1(3%) with DM, HTN, hyperlipidemia
and congestive heart failure (CHF). Of the 30 participants in the intervention group who
received a phone call and completed the MAS, 28 were high school graduates and 2 were
college graduates, 26 were between the age of 65 to 75 years old and 8 were between the
ages of 76 to 82 years old.
Female Male05
1015202530354045
MaleFemale
Figure1. Participants' Gender
One chronic disease Two chronic diseases more than one chronic diseases
0
5
10
15
20
25
Number of Chronic Illnesses
Figure 2. Number of Chronic Illnesses of Participants
54
Education level
High SchoolCollege Graduate
Figure 4. Participants' Education Level
This section included a presentation of participants' demographic characteristics. The
succeeding sections provided the data analysis procedures employed to address the
clinical questions posed in the project. After which, the results of statistical analyses were
presented.
Data Analysis Procedures
The data collected were used to answer both clinical questions. The first clinical
question that was answered is was: To what degree does a weekly phone call and the
administration of HB-MAS increase compliance in geriatric patients? The second
clinical question was: What was the relationship between a weekly phone call and the
administration of an HB-MAS in medication compliance in noncompliant geriatric
patients?
The questionnaire was developed to establish valid scientific outcomes, hence when
developing the questionnaires, consideration to achieve accuracy and trustworthiness was
made. The development considered high inter-item correlations and a Cronbach's
reliability value of at least 0.70. The quantitative method was used along with the SPSS
55
to analyze the data.
Utilizing the correlational project design, the degree of compliance pre-and-post-
intervention was compared and barriers to compliance were identified. The data was
collected over a period of six weeks. Some of the descriptive data that were used are age,
gender, number of chronic diseases, and name of chronic diseases. Inferential statistical
analysis was used, utilizing the statistical software of SPSS, and a t-test was performed to
determine statistical significance. The use of a t-test was appropriate because the focus of
the project was to compare pre and post-test compliance data in geriatric patients.
Results
As stated, the investigator used repeated-measures ANOVA to determine the
relationship between a weekly phone call and the administration of a MAS to increase
medication compliance among geriatric patients with chronic diseases. This was
conducted to aid the investigator at answering the two clinical questions: (1) To what
degree does a weekly phone call and the administration of MAS increase compliance in
geriatric patients? (2) What was the relationship between a weekly phone call and the
administration of a MAS in medication compliance in noncompliant geriatric patients?
First, the responses on the MAS were evaluated to look for improvement in medication
adherence behavior. Then, the scores were evaluated along with the biomarker for an
indication of medication adherence patterns.
56
Descriptive statistics for the variables of interest. Univariate analysis was
conducted using the dataset to generate descriptive statistics. Univariate analysis is a
standard procedure that typically involves the computation of means, medians, standard
deviations, and other descriptive data, usually to gain a comprehensive overview of the
dataset and to screen for outliers. Additionally, univariate analysis can be helpful for
readers to assess the generalizability of study results. Table 1 shows descriptive statistics
summaries for the MAS scores of medication compliance at pre-test and post-test
between the non-interventional and interventional group.
For the non-intervention group, the mean MAS score at post-test (M = 9.97, SD =
3.69) was significantly lower than the mean MAS score at pre-test (M = 10.03, SD =
3.68). Also, for the intervention group, the mean MAS score at post-test (M = 6.90, SD =
1.58) was significantly lower than the mean MAS score at pre-test (M = 10.53, SD =
3.73). Comparison of the mean MAS scores showed that the MAS scores among the 30
geriatric patients with chronic illnesses in the non-intervention group and 30 geriatric
patients with chronic illnesses in the intervention group have a decreasing trend in the
MAS scores from the pre-test to the post-test. It should be noted that high scores in the
survey indicate that patients have fewer adherences to the medication prescription, while
lower scores indicate more adherences. A comparison of the MAS scores at the post-test
between the two sample groups showed that the mean MAS scores for the intervention
group (M = 6.90, SD = 1.58) were also significantly lower than for the non-intervention
group (M = 9.97, SD = 3.69). However, the significance of the difference of the MAS
scores will be investigated in the repeated measures ANOVA.
Table 1
Descriptive Statistics Summaries of MAS Scores at Pre-test and Post-test (N = 60)
57
Time Group M SD N
Pre-test (week 1) Non-intervention 10.03 3.68 30
Intervention 10.53 3.73 30
Total 10.28 3.68 60
Post-test (week 6) Non-intervention 9.97 3.69 30
Intervention 6.90 1.58 30
Total 8.43 3.21 60
58
Test of required assumption of the parametric test. The repeated-measures
ANOVA was conducted to address the research objectives. This statistical analysis is a
parametric test that requires certain assumptions before conducting the test. The different
required assumptions of this test include no presence of outliers in the data set, normality
of the data of the dependent variable, and homogeneity of variance. Each of these
assumptions was tested and the results are presented below.
Outlier investigation. The first required assumption states that there should be no
presence of outliers in the data set. Again, investigation of the presence of outliers of the
final dataset including the 30 geriatric patients with chronic illnesses in the non-
intervention group and 30 geriatric patients with chronic illnesses in the intervention
group was conducted through visual inspection of the boxplot for each of the data of
MAS scores at pre-test and post-test. The boxplots are summarized in Figures 5 to 6.
Investigation of the boxplot of the data MAS scores at the pre-test for both intervention
and non-intervention groups (Figure 5) showed no presence of outliers. Investigation of
the boxplot of the data MAS scores at post-test for both intervention and non-intervention
groups (Figure 6) also showed no presence of outliers. Thus, the no presence of outline
assumption was satisfied.
59
Figure 5. MAS Score at Pre-test
Figure 6. MAS Score at Post-test
Normality. The second assumption tested the assumption of normality, meaning
that the data of the dependent variable should exhibit a normal distribution. Normality
was tested using the Shapiro-Wilk test. The results of the Shapiro-Wilk test are shown in
Table 2.
60
Results of the Shapiro-Wilk test showed that the data of the MAS scores at pre-
test for both intervention group (SW(30) = 0.95, p = 0.14) and non-intervention group
(SW(30) = 0.95, p = 0.12) followed normal distribution while only the data of the MAS
scores at post-test for the non-intervention (SW(30) = 0.94, p = 0.11) followed normal
distribution. Normal distribution was based on the Shapiro-Wilk statistics having a p-
value greater than the level of significance, set at 0.05, which was the case of the results.
However, investigation of the normal test result for the data of the MAS score at the post-
test for the intervention (SW(30) = 0.85, p < 0.001) did not follow a normal distribution.
Although the data did not follow a normal distribution, the statistical analysis of ANOVA
was used and is robust to the violation of normality (Blanca, Alarcon, Arnau, Bono, &
Bendayan, 2017). This allowed for the analysis to go on as planned. With these results,
the assumption of normality was satisfied by data of three out of the four dependent
variables.
Table 2
Shapiro-Wilk Test of Normality of Data of Dependent Variables
61
Period Group Shapiro-Wilk
Statisti
c
df p
Pre-test (week 1) Non-intervention 0.95 3
0
0.1
4
Intervention 0.95 3
0
0.1
2
Post-test (week
6)
Non-intervention 0.94 3
0
0.1
1
Intervention 0.85 3
0
0.0
0
62
Homogeneity of covariance. The fifth assumption tested is homogeneity or
equality of covariance. The assumption of equal covariance was tested using Box’s tests
of equality of covariance matrices. The p-value of the Box’s test of equality of
covariance matrix should be greater than the level of significance value of 0.05 to prove
that the covariance of the dependent variables is equal or homogenous across the
different categorical groups of the independent variables. The results of the Box’s test of
equality of covariance matrices showed that the covariance of the dependent variable of
MAS scores at pre-test and post-test was homogenous across the two samples groups of
non-intervention and intervention of the geriatric patients with chronic illnesses (Box's M
= 18.75, F(3, 605520) = 6.02, p < 0.001). Thus, the homogeneity of covariance
assumption was violated.
Homogeneity of variance. The sixth and final assumption tested was the
homogeneity of or equality of variances. Levene’s test was conducted to determine
whether the variances of the different dependent variables of MAS scores are
homogeneous across the different categories/groupings of the independent variable. The
results of the Levene’s test are shown in Table 3.
63
Results of the Levene’s test showed that only the variance of MAS scores at pre-
test (F(1, 58) = 0.20, p = 0.65) was homogenous or equal across the two sample groups of
non-intervention and intervention groups. Homogeneity of variances was achieved based
on Levene’s statistics with the p-value greater than the level of significance set at 0.05.
On the other hand, the variance of the MAS scores at post-test (F(6, 25) = 21.18, p <
0.001) was not homogenous or unequal across the two sample groups of non-intervention
and intervention groups. Thus, the homogeneity of variances assumption was violated.
However, it should be noted that the ANOVA utilize F statistics, which are generally
robust to violations of the assumption as long as group sizes are equal, which is the case
of the study (non-intervention group: n = 30, intervention group: n = 30). Equal group
sizes are defined by the ratio of the largest to the smallest group being less than 1.5
(Tabachnick & Fidell, 2013). Thus, the homogeneity of variance assumption was still
satisfied by all dependent variables in the study.
Table 3
Levene’s Test of Homogeneity of Variances
Period F df1 df2 p
Pre-test (week 1) 0.20 1 58 0.65
Post-test (week 6) 21.18 1 58 0.00
Tests the null hypothesis that the error variance of the dependent variable
is equal across groups.
a. Design: Intercept + Group
Within Subjects Design: time
64
Repeated Measures ANOVA Results. A repeated-measures ANOVA was
conducted to determine whether the MAS scores to measure medication compliance of
geriatric patients with chronic illnesses were significantly different at pre-test and post-
test between the two sample groups of non-intervention and intervention group. This
analysis determined whether the MAS scores to measure medication compliance between
geriatric patients with chronic illnesses that participated in the intervention of weekly
phone call and the administration of a MAS (intervention group) versus those that
geriatric patients with chronic illnesses that did not participate in the intervention (non-
intervention group) were significantly different at different time periods of measurement
(pre-test versus post-test). As stated, a level of significance of 0.05 was used in the
repeated measures ANOVA. The significance of the effect of the intervention of weekly
phone call and the administration of a MAS on the MAS scores as a measure of
medication compliance is determined by investigating the differences of scores at the
different year periods between samples at the non-intervention and intervention group.
There are significant differences if the p-value of the F statistic is less than the level of
significance value set at 0.05.
65
Table 4 summarizes the results of the between-participants effects of the
invention on the MAS scores or the differences in the MAS scores between non-
intervention and intervention group. Results of the between-subjects effects showed that
the MAS scores between the non-intervention group and intervention group were
significantly different (F (1, 58) = 3.84, p = 0.05) at the level of significance of 0.05.
There was a significant difference since the p-value was less than the level of significance
value of 0.05. This means that the compliance rate with medication regimen between
geriatric patients with chronic illnesses that participated in the intervention of weekly
phone call and the administration of a MAS (intervention group) versus those that
geriatric patients with chronic illnesses that did not participate in the intervention (non-
intervention group) were significantly different. Comparison of the total mean MAS
scores in Table 1 showed that the mean MAS score at post-test for geriatric patients with
chronic illnesses in the intervention group (M = 6.90; SD = 1.58) was significantly lower
than geriatric patients with chronic illnesses in the non-intervention group (M = 9.97; SD
= 3.69). This indicated that the geriatric patients with chronic illnesses that participated
in the intervention of weekly phone call and the administration of a MAS have higher
compliance rate with medication regimen as compared to the geriatric patients with
chronic illnesses that did not participate in the intervention of weekly phone call and the
administration of a MAS.
Table 4
Repeated Measures ANOVA Results of Between-Subjects Effects of Intervention
on MAS Scores
66
Source
Type III
Sum of
Squares
dfMean
SquareF p
Partial Eta
Squared
Intercept 10509.41 1 10509.41 816.34 0.00 0.93
Group 49.41 1 49.41 3.84 0.05* 0.06
67
Error 746.68 58 12.87
68
*Significant difference at level of significance of 0.05
Table 5 presents the results of the test of within-subjects effects. This determined
the main effect of whether the repeated measures of the MAS score were significantly
different at pre-test and post-test. The analysis also determined the interaction effect of
whether the repeated measures and intervention had a two-way influence on the MAS
scores of the geriatric patients with chronic illnesses. Results test of within-subjects
effects showed that the MAS scores at pre-test and post-test of the geriatric patients with
chronic illnesses were significantly different (F(1, 58) = 10.71, p < 0.002). Looking at
the descriptive statistics in Table 1, it can be seen that the mean MAS score at post-test
(M = 9.97, SD = 3.69) was significantly lower than the mean MAS score at pre-test (M =
10.03, SD = 3.68) for the non-intervention group; while the mean MAS score at post-test
(M = 6.90, SD = 1.58) was significantly lower than the mean MAS score at pre-test (M =
10.53, SD = 3.73) for the intervention group. Comparison of the mean MAS scores
showed that the MAS scores among the 30 geriatric patients with chronic illnesses in the
non-intervention group and 30 geriatric patients with chronic illnesses in the intervention
group have a decreasing trend in the MAS scores from the pre-test to the post-test. This
means that both geriatric patients with chronic illnesses in the non-intervention group and
intervention group have greater adherence in medication prescription at the post-test than
at the pre-test.
69
On the other hand, the interaction between the repeated measures (pre-test versus
post-test) and intervention also had a significant effect on the MAS scores (F(1, 58) =
10.70, p = 0.002) on the geriatric patients with chronic illnesses. This means that there
was a significant difference in the MAS scores of geriatric patients with chronic illnesses
at pre-test and post-test because of the intervention. A comparison of the MAS scores at
the post-test between the two sample groups showed that the mean MAS scores for the
intervention group (M = 6.90, SD = 1.58) were also significantly lower than for the non-
intervention group (M = 9.97, SD = 3.69). This means that geriatric patients with chronic
illnesses that participated in the intervention of weekly phone call and the administration
of a MAS have higher compliance rates with medication regimen as compared to the
geriatric patients with chronic illnesses that did not participate in the intervention. The
result of the project showed a significant increase in compliance among the group of 30
participants that received a weekly phone call and complete a MAS over the six weeks
period. Approximately 95% of all participants showed an increase in compliance with a
decrease in the MAS scores. Also, results showed that a weekly phone call can positively
impact the level of compliance in the geriatric population. The decreases in the MAS
scores from pre-test to post-test positively reflected what the investigator set out to
evaluate, which was the relationship between a weekly phone call, and the administration
of a MAS, and improved medication compliance.
Table 5
Repeated Measures ANOVA Results on MAS Scores
70
Source time
Type III
Sum of
Squares
dfMean
SquareF p
Partial Eta
Squared
time Linear 102.68 1 102.68 11.51 0.001* 0.17
time *
GroupLinear 95.41 1 95.41 10.70 0.002* 0.16
Error(time) Linear 517.42 58 8.92
*Significant difference at level of significance of 0.05
Summary
Improving medication compliance among the geriatric population is of the utmost
importance. In general, only 50% of the general population has been estimated to adhere
to their medications, and this may range from 47 to 100% in the elderly (Shrutthi et al.,
2016). Despite numerous studies, poor compliance among older persons remains a public
health concern, as it accounts for adverse outcomes, medication wastage with an
increased cost of healthcare, and substantial worsening of the disease with increased
disability or death. (Sshurutti, et. al, 2016). Also, noncompliance grossly contributes to
avoidable hospitalization and re-hospitalization after discharge.
The purpose of this project was to identify whether any relationship exists between
a weekly phone call and MAS to increase medication compliance. The education
provided weekly would hopefully help provide the necessary information to the
participants aiding at increasing compliance. The result of the repeated measures
ANOVA showed there was a significant increase in compliance among the geriatric
patients with chronic diseases that received a weekly phone call and complete a MAS
71
over the six weeks period. Also, results showed that the compliance rate with medication
regimen between geriatric patients with chronic illnesses that participated in the
intervention of weekly phone call and the administration of a MAS (intervention group)
versus those that geriatric patients with chronic illnesses that did not participate in the
intervention (non-intervention group) were significantly different. Specifically, geriatric
patients with chronic illnesses that participated in the intervention of weekly phone call
and the administration of a MAS have higher compliance rates with medication regimen
as compared to geriatric patients with chronic illnesses that did not participate in the
intervention.
In the following chapter, Chapter five concludes this study. Chapter five includes a
summary of the project, a discussion of the findings, conclusions, the implications of the
findings, and recommendations based on the results of the present project.
Chapter 5: Summary, Conclusions, and Recommendations
The goal of this project was to determine if a weekly phone call and the
completion of MAS would increase compliance among geriatric patients. Several studies
have demonstrated that insufficient medication adherence among older adults can result
in worsening clinical outcomes, including re-hospitalization, exacerbation of chronic
72
medical conditions, and greater healthcare costs. Up to 10% of hospital readmissions
have been attributed to non-adherence. Previous investigators have indicated that poor
medication adherence is associated with higher risks of morbidity, hospitalization,
mortality and was also associated with many adverse health outcomes (Verloo, Chiolero,
Kiszio, Kampel & Santschi, 2017).
This project aimed to identify if there is a relationship between a weekly phone
call and the administration of an HB-MAS to increase medication compliance. These
findings have indicated that such a relationship exists. These findings were mostly
supported by the literature, as will be discussed further on. Findings also have
implications on the use of phone call interventions by nurse practitioners. This study
extends the knowledge of alternative ways to promote medication adherence in geriatric
patients.
Summary of the Project
This project involved a quantitative investigation of the relationship between a
weekly phone call and the administration of MAS to increase medication compliance.
The study involved two groups with intervention in one group. The intervention was six
weeks of weekly phone calls and the administration of MAS. The main clinical questions
for this study were: Q1. To what degree does the implementation of a MAS via weekly
phone call increase medication compliance among geriatric patients with chronic
diseases? and Q2. What is the relationship between the patients who are participating in
the weekly MAS and the patients who are not participating? The remainder of this
chapter will include a summary of the project, a summary of the findings and conclusion,
discussion and implication of the findings, and the conclusion and recommendations
based on the results. The HBM theoretical framework, was used to guide the
73
interpretation and implications of the findings. Findings from previous projects will be
juxtaposed with the present project to determine how the results fit in with existing
knowledge.
Summary of Findings and Conclusion
The findings of this study answered the two research questions presented above.
The first key finding of this study revealed the individual predictors of medical adherence
in relation to the intervention involving a phone call and the administration of an HB-
MAS. The level of education was significantly and positively related to medication
adherence, particularly from the fourth to the sixth week of intervention. This is in line
with the HBM, which considers demographic factors such as educational levels as
possible influencers of medical adherence (Mayeye, Ter Goon, & Yako, 2019). The
present study’s first key finding indeed revealed that demographic factors may be
influential in medication adherence for the geriatric population.
Previous studies have highlighted the influence of level of education on
medication adherence in various countries and concerning various illnesses. In Kokturk et
al.’s (2018) study of chronic obstructive pulmonary disease (COPD) patients in Turkey
and Saudi Arabia, they noted that high school and college graduates were more adherents
to medication compared to non-graduates. The level of education could somehow reflect
the level of understanding in a patient, which could thus influence their adherence to
medical instructions, especially if these instructions are complicated (Kokturk et al.,
2018). Similarly, a study on elderly hypertensive patients in Cairo, Egypt likewise
showed that higher educational attainment was positively related to better medical
adherence (Hamza, El Akkas, Abdelrahman, & Abd Elghany, 2019). Educational
attainment was found to be related to health literacy, which in turn influenced medical
74
adherence (Scoones et al., 2017). These previous findings showed support for the present
study’s finding that level of education could be a factor in the relationship between
intervention and medication adherence in geriatric patients.
The second key finding of this project was that there was a significant increase in
compliance for the group who received a weekly phone call and completed an HB-MAS
within six weeks. The result of this project is aligned with Daniel, Christian, Robin, Lars,
and Thomas’s (2019) findings that intervention for geriatric patients through telephone
significantly improved medication adherence for acute coronary syndrome. They noted
that commonly cited reasons for their control group, including non-compelling side
effects and misunderstandings, were not present in their intervention group. This showed
the educational value of phone call interventions in reaching patients and improving their
adherence (Daniel et al., 2019). Another study supporting the present study’s finding was
by Huang et al. (, 2013), who found through their study of effects of a phone call as an
intervention to promote antiviral adherence, that there was a significant increase in
physical wellbeing amongst patients who received interventional phone calls. Results
showed that a phone call intervention could maintain high self-reported adherence to
patients. In a randomized trial conducted by Huang et, al. (2013) it was found that
patients who received short mobile message support had significantly improved
antiretroviral therapy (ART) adherence and rates of viral suppression compared with the
control individuals. Mobile phones might be effective tools to improve patient outcomes
in resource-limited settings.
Previous projects have also explored the advantages and possible disadvantages of
monitoring patients via telephone. Telemonitoring, the term for monitoring patients
through phone calls, was found to reduce both short- and long-term hospitalization rates
75
(Tse et al., 2018). Healthcare practitioners can keep up to date with a patient’s status,
including heart rate, blood pressure, body weight, and other vital information through the
telephone provided the patient had the proper equipment at home. At the same time,
healthcare practitioners can also give advice and increase patients’ self-efficacy through
the telephone, thereby improving their medical adherence (Tse et al., 2018). Even the
simple act of reminding patients to refill and take their medication was purported to help
patients, especially those with chronic illnesses that needed continuous medication (Costa
et al., 2015). On a negative note,
Saragosa et al. (2020) warned against the issue of patient privacy in using phone
calls and other electronic methods. Practitioner-patient confidentiality may not be as
secure in phone calls, which can easily be recorded, as it is in personal meetings
(Saragosa et al., 2020). Nonetheless, phone call interventions provide a convenient and
cost-effective method for patients who are unable to be physically present.
The findings of this project have implications for theory, practice, and the future.
For theory, the findings supported the HBM, which served as the theoretical framework
of the study. In terms of practice, findings show support for the use of weekly phone calls
and MAS to improve medication adherence among geriatric patients. Findings also have
implications for the future of nursing research.
Implications
The findings of this study have implications for theory, practice, and the future. For
theory, the findings supported the HBM, which served as the theoretical framework of
the study. In terms of practice, findings show support for the use of weekly phone calls,
76
and the administration of an HB-MAS to improve medication adherence among geriatric
patients. Findings also have implications for the future of nursing research.
Theoretical implications. For this project, the HBM was used. It explains that a
person’s health-seeking behaviors depend on whether they feel that condition or disease
presents a danger to them or their loved ones (Becker, 1974; Rosenstock, 1990). The
model considers (a) the severity of the illness in question, (b) one’s susceptibility to this
disease, (c) the advantages of attempting to prevent the disease, and (d) the barriers that
prevent one from acting to prevent the condition (Nursing Theories, 2012; Willis, 2018).
The theory also emphasizes cues to prompt action, which in this case is medical
adherence, and self-efficacy (Lemanek & Yardley, 2019; Willis, 2018). The weekly
phone calls served as both cues to action and a means for improving self-efficacy.
The project supported the HBM theory with its findings. The theoretical
implication of the findings is that the HBM may influence the decision-making processes
of the geriatric population by accepting and understanding that complying with their
medication regimen will improve their outcomes (Rosenstock, 1990). The HBM’s
weighing in of benefits and barriers to medical adherence allows geriatric patients to
realize that the positive outcomes outweigh the negative ones (Willis, 2018). The
healthcare provider’s role, therefore, is to make every effort to first and foremost educate,
encourage, and assist the geriatric patients at becoming compliant and thereby positively
improve health outcomes. The findings of the present study thus extend the knowledge
related to HBM, revealing how it can be applied, even though phone calls, to geriatric
patients’ medical adherence.
Practical implications. This project’s goal was geared toward practice
improvement. Finding ways to increase compliance will help in improving patient
77
outcomes. Strict medical adherence can improve health outcomes more so than treatment
itself (Kim, Combs, Downs, & Tillman, 2018). Technological strategies such as phone
calls can be utilized by healthcare providers to provide services for their geriatric patients
(Kim et al., 2018). Personalized interventions, which can be done with such calls and
with the guidance of MAS, are particularly important for geriatric patients as well, as this
population may be more at risk for errors (Van Boven et al., 2018). Consequently, this
project has proven that a weekly phone call can make a significant impact in improving
medication compliance in the geriatric population.
Enhanced medical adherence not only improves patient outcomes but also has
implications for costs. Patients who do not strictly adhere to their medication are at a
higher risk for mortality and morbidity (Midão, Giardini, Menditto, Kardas, & Costa,
2017). The enhanced health outcomes brought by low-cost phone call interventions could
mean less expenditure involving other healthcare costs. The findings thus imply that
healthcare providers could utilize cost-effective interventions, such as the weekly phone
calls, for better health outcomes and decreased costs.
Future implications. This project offered an insight into medication compliance.
It outlined the success that an intervention can increase compliance. This can have huge
benefits within the health care industry as simple, cost-effective, corrective actions can
help strengthen adherence, especially with limited resources (Midão et al., 2017).
However, this study did not compare and contrast other programs. A comparison could
indicate which types of programs are more cost and time effective. Additionally, it
would be interesting to know how patients feel about the program and if it is easier on
them. The findings thus imply further inquiry into such medical adherence interventions
to advance knowledge in the field of nursing.
78
Recommendations
Recommendations for future projects. Although this project has a strong
design, a good theoretical foundation, and a positive finding, the sample size was too
small and the timeframe was too short. This project was limited to a small private clinic
with low-income families who are mostly insured by the government. The participants
were mostly of one culture and ethnicity. Recommendation for future investigation
would suggest a larger sample, a longer timeframe, a more diverse population. Also,
including privately insured participants to ensure validity and reliability.
The inclusion of more diverse samples may also allow for more comparisons in
terms of demographics. Factors other than educational level should be considered as
possible predictors for medication adherence, such as race, geographic location, and
occupation. These predictors would help nurse practitioners to model their interventions
accordingly.
As aforementioned, future projects should also examine and other adherence
programs in comparison to the one in the present study. An intervention utilizing other
electronic media would be interesting, especially for the geriatric population who may
not be as technologically savvy as other populations. Other comparable interventions
could include clinical or therapeutic interventions. A comparison between these different
types of interventions would help determine which type would be best utilized for
geriatric patients.
Finally, future investigators could utilize qualitative designs to explore the
perspectives of both patients and healthcare practitioners regarding the intervention.
Patients could be interviewed regarding their preference and ease of use of the
intervention. Healthcare practitioners such as physicians, nurses, and even pharmacists,
79
could be interviewed to gather their opinions on such interventions. A Delphi study could
even be conducted to gather expert opinion on the utility of the intervention.
Recommendations for practice. It is also recommended that healthcare
providers take time to have a conversation about medication compliance with their
patients. Personalized interventions are most effective for patients prone to error (Van
Boven et al., 2018). Geriatric patients may have more needs than regular patients and
may need more education and reminders to adhere to their medications. Medication
instructions for geriatric patients should also be clearer and easier to follow (Midão et al.,
20187). In line with the present study’s findings regarding the level of education, the
instructions provided through the intervention should be modified to suit the needs of the
patient, as some may not fully understand the instructions. The use of phone calls could
be a cost-effective way to provide such personalized care, as it does not require the
patient to be physically present but still allows them to communicate clearly and openly
with their healthcare practitioners.
Healthcare practitioners should not only provide informational and educational
support for patients but also psychological support. In accordance with the HBM, patients
must have adequate self-efficacy to properly comply with their medication instructions
(Willis, 2018). Healthcare practitioners should be encouraging and responsive to the
needs of geriatric patients. They should consider the patients’ perspectives regarding
possible barriers in medication adherence and provide possible alternatives to such
barriers. They should also increase patient involvement in the process. One way to
include the patient is to utilize MAS so that patients could observe their adherence
practices for themselves. Through the personalized weekly phone calls, healthcare
practitioners could check up on the well-being of their patients and provide psychological
80
support to them.
Aside from phone call interventions, other interventions have been presented in
the literature, such as face-to-face types of interventions (Kim et al., 2018). Practitioners
could benefit greatly from examining these studies for an intervention that they would
deem appropriate and suitable for their patients. They should seek evidence-based
practices that have been proven to aid in increasing compliance.
Summary
With this project, the investigator was able to confirm poor medication adherence
among the geriatric population. This study was to investigate the effects of interventions
such as a weekly phone call and an administration of a MAS as it relates to medication
compliance among the geriatric population. The HBM was used as a theoretical
framework to guide the study, considering patients’ severity of illness, susceptibility,
advantages of adherence, barriers to adherence, and cues to action. These principles
guided the overall process of the study including the intervention and interpretation of the
results.
The results of the project revealed a significant increase in compliance for
geriatric patients who received a weekly phone call and completed MAS. Such findings
revealed that the simple and cost-effective act of calling and conversing with patients
could positively influence their medical adherence. The level of compliance was assessed
by the use of an HB-MAS and it positively correlates with educational level, age, number
of chronic diseases, and gender. The results of this project showed an increase in
compliance along with normalization vital signs and biomarkers. These findings implied
that personalization was also important in providing intervention to geriatric patients, as
each patient may have different needs. Weekly phone calls would allow healthcare
81
professionals to provide personalized care at a low cost for patients who may not be able
to be physically present in clinical or therapeutic interventions. The present project’s
findings thus show support for cost-effective interventions to provide informational,
educational, and psychological support for geriatric patients in terms of medication
adherence.
82
References
Althubaiti, A. (2016). Information bias in health research: Definition, pitfalls, and
adjustment methods. Journal of Multidisciplinary Healthcare, 9, 211–217.
https://dx.doi.org/10.2147%2FJMDH.S104807
Anglada‐Martinez, H., Riu‐Viladoms, G., Martin‐Conde, M., Rovira‐Illamola, M.
Sotoca‐Momblona, J. M., & Codina‐Jane, C. (2015). Does mHealth increase
adherence to medication? Results of a systematic review. International Journal of
Clinical Practice, 69(1), 9–32. https://doi.org/10.1111/ijcp.12582
Baktash, M. Q., & Naji, A. B. (2019). Efficacy of health belief model in enhancing
exercise behavior to preventing stroke among geriatrics homes residents in
Baghdad City. Indian Journal of Public Health Research & Development, 10(2),
928–933. http://dx.doi.org/10.5958/0976-5506.2019.00415.7
Balkrishnan, R. (2005). The importance of medication adherence in improving chronic-
disease related outcomes: What we know and what we need to further know.
Medical Care, 43(6), 517–520.
https://doi.org/10.1097/01.mlr.0000166617.68751.5f
Batsis, J. A., Germain, C. M., Vásquez, E., & Bartels, S. J. (2016). Prevalence of
weakness and its relationship with limitations based on the Foundations for the
National Institutes for Health project: Data from the Health and Retirement Study.
European Journal of Clinical Nutrition, 70(10), 1168–1173.
https://dx.doi.org/10.1038%2Fejcn.2016.90
83
Bazargan, M., Smith, J., Yazdanshenas, H., Movassaghi, M., Martins, D., &, Orum, G.
(2017). Non-adherence to medication regimens among older African-American
adults. BioMed Central Geriatrics, 17(1), Article 163.
https://doi.org/10.1186/s12877-017-0558-5
Becker, M. H. (1974). The health belief model and personal health behavior. Health
Education Monographs 2(12), 324–508. Retrieved from
https://www.scienceopen.com/document?vid=07fd279a-70d4-4783-9923-
42605b497648
Bercier, M. L., & Maynard, B. R. (2015). Interventions for medication noncompliance: A
systematic review. Research on Social Work Practice, 25(1), 81–89. Retrieved
from https://journals.sagepub.com/home/rsw
Blanca, M., Alarcon, R., Arnau, J., Bono, R., & Bendayan, R. (2017). Non-normal data:
Is ANOVA still a valid option? Psicothema, 29(4), 552-557. doi:
10.7334/psicothema2016.383
Boulos, M. N. K., Wheeler, S., Tavares, C., & Jones, R. (2011). How smartphones are
changing the face of mobile and participatory healthcare: An overview, with
example from eCAALYX. Biomedical Engineering Online, 10(1), Article 24.
https://doi.org/10.1186/1475-925X-10-24
Brannen, J. (2017). Mixing methods: Qualitative and quantitative research. New York,
NY: Routledge.
BrarPrayaga, R., Jeong, E., Feger, E., Noble, H., Kmiec, M., & Prayaga, R. (2018).
Improving refill adherence in Medicare patients with tailored and interactive
mobile text messaging: Pilot study. JMIR Mhealth and Uhealth, 6(1), e30.
https://doi.org/10.2196/mhealth.8930
84
Braun, R., Catalani, C., Wimbush, J., & Israelski, D. (2013). Community health workers
and mobile technology: A systematic review of the literature. PloS One, 8(6),
e65772. https://dx.doi.org/10.1371%2Fjournal.pone.0065772
Brown, M. T., & Bussell, J. K. (2011, April). Medication adherence: WHO cares? In
Mayo clinic proceedings (Vol. 86, No. 4, pp. 304–314). New York, NY: Elsevier.
Bryman, A. (2017). Quantitative and qualitative research: Further reflections on their
integration. In Mixing methods: Qualitative and quantitative research (pp. 57–
78). New York, NY: Routledge.
Chang, K. C., Wang, J. D., Tang, H. P., Cheng, C. M., & Lin, C. Y. (2014). Psychometric
evaluation, using Rasch analysis, of the WHOQOL-BREF in heroin-dependent
people undergoing methadone maintenance treatment: Further item validation.
Health and Quality of Life Outcomes, 12(1), Article 148.
https://doi.org/10.1186/s12955-014-0148-6
Chia, L. R., Schlenk, E. A., & Dunbar-Jacob, J. (2006). Effect of personal and cultural
beliefs on medication adherence in the elderly. Drugs & Aging, 23(3), 191–202.
https://doi.org/10.2165/00002512-200623030-00002
Chisholm-Burns, M. A., & Spivey, C. A. (2012). The cost of medication nonadherence:
Consequences we cannot afford to accept. Journal of the American Pharmacists
Association, 52(6), 823–826. https://doi.org/10.1331/JAPhA.2012.11088
Choi, A., Lovett, A. W., Kang, J., Lee, K., & Choi, L. (2015). Mobile applications to
improve medication adherence: Existing apps, quality of life and future directions.
Advances in Pharmacology and Pharmacy, 3(3), 64–74.
https://doi.org/10.13189/app.2015.030302
85
Chung, G. C., Marottoli, R. A., Cooney, L. M., Jr., & Rhee, T. G. (2019). Cost‐Related
Medication nonadherence among older adults: Findings from a national
representative sample. Journal of the American Geriatrics Society, 67(12), 2463–
2473. https://doi.org/10.1111/jgs.16141
Costa, E., Giardini, A., Savin, M., Menditto, E., Lehane, E., Laosa, O., . . . Marengoni, A.
(2015).Interventional tools to improve medication adherence: Review of
literature. Patient Preference and Adherence, 9, 1303–1314.
https://doi.org/10.2147/PPA.S87551
Cutler, R., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V.
(2018). Economic impact of medication non-adherence by disease groups: A
systematic review. BMJ Open, 8(1), e016982. https://doi.org/10.1136/bmjopen-
2017-
Daniel, H., Christian, W., Robin, H., Lars, S., & Thomas, M. (2019). Statin treatment
after acute coronary syndrome: Adherence and reasons for non-adherence in a
randomized controlled intervention trial. Scientific Reports, 9(1).
doi:10.1038/s41598-019-48540-3
Davy, C., Bleasel, J., Liu, H., Tchan, M., Ponniah, S., & Brown, A. (2015). Effectiveness
of chronic care models: Opportunities for improving healthcare practice and
health outcomes: A systematic review. BioMed Central Health Services
Research, 15(1), Article 194. https://doi.org/10.1186/s12913-015-0854-8
Delaney, L. J. (2018). Patient-centered care as an approach to improving health care
Australia. Collegian, 25(1), 119–123.
https://doi.org/10.1016/j.colegn.2017.02.005
86
Dhillon, A. K., Hattingh, H. L., Stafford, A., & Hoti, K. (2015). General practitioners’
perceptions on home medicines reviews: A qualitative analysis. BioMed Central
Family Practice, 16(1), Article 16. https://doi.org/10.1186/s12875-015-0227-8
Ellis-Barton, C. (2016). Ethical considerations in research participation virality. Journal
of Empirical Research on Human Research Ethics, 11(3), 281–285.
https://doi.org/10.1177%2F1556264616661632
El-Mallakh, P., & Findlay, J. (2015). Strategies to improve medication adherence in
patients with schizophrenia: The role of support services. Neuropsychiatric
Disease and Treatment, 11, 1077–1090.
https://dx.doi.org/10.2147%2FNDT.S56107
El-Saifi, N., Moyle, W., Jones, C., & Alston-Knox, C. (2019). Determinants of
medication adherence in older people with dementia from the caregivers’
perspective. International Psychogeriatrics, 31(3), 331–339.
https://doi.org/10.1017/S1041610218000583
Etikan, I., Musa, S. A., & Alkassim, R. S. (2016). Comparison of convenience sampling
and purposive sampling. American Journal of Theoretical and Applied Statistics,
5(1), 1–4. https://doi.org/10.11648/j.ajtas.20160501.11
Fischer, M. A., Stedman, M. R., Lii, J., Vogeli, C., Shrank, W. H., Brookhart, M. A., &
Weissman, J. S. (2010). Primary medication non-adherence: Analysis of 195,930
electronic prescriptions. Journal of General Internal Medicine, 25(4), 284–290.
https://doi.org/10.1007/s11606-010-1253-9
87
Foot, H., La Caze, A., Gujral, G., & Cottrell, N. (2016). The necessity-concerns
framework predicts adherence to medication in multiple illness conditions: A
meta-analysis. Patient Education and Counseling, 99(5), 706–717.
https://doi.org/10.1016/j.pec.2015.11.004
Frances, A., Thirumoorthy, T., & Kwan, Y. H. (2016). Medication adherence in the
elderly. Journal of Clinical Gerontology and Geriatrics, 7(2), 64–67.
https://doi.org/10.1016/j.jcgg. 2015.05.001
Jimmy, B., & Jose, J. (2011). Patient medication adherence: Measures in daily practice.
Oman Medical Journal, 3, 155. Retrieved from https://search-ebscohost-
com.lopes.idm.oclc.org/login.aspx?
direct=true&db=edsgao&AN=edsgcl.259680803&site=eds-live&scope=site
Jin, H., Kim, Y., &Rhie, S. J. (2016). Factors affecting medication adherence in elderly
people. Patient Preference and Adherence, 10, 2117–2125.
https://doi.org/10.2147/PPA.S118121
Haase, J., Farris, K. B., & Dorsch, M. P. (2017). Mobile applications to improve
medication adherence. Telemedicine and e-Health, 23(2), 75–79.
https://doi.org/10.1089/tmj.2015.0227
Halcomb, E., & Hickman, L. (2015). Mixed methods research. Nursing Standard, 29(32),
41–47. https://doi.org/10.7748/ns.29.32.41.e8858
Hamza, S. A., El Akkad, R. M., Abdelrahman, E. E., & Abd Elghany, S. A. (2019). Non
adherence to Antihypertensive medications among hypertensive elderly patients
in outpatient geriatric clinic. The Egyptian Journal of Geriatrics and
Gerontology, 6(1), 1-7. doi:10.21608/EJGG.2019.30888
88
Hicks, C. M. (2009). Research methods for clinical therapists e-book: Applied project
design and analysis. New York, NY: Elsevier Health Sciences.
Holt, E. W., Rung, A. L., Leon, K. A., Firestein, C., & Krousel-Wood, M. (2014).
Medication adherence in older adults: A qualitative study. Educational
Gerontology, 40(3), 198–211. https://doi.org/10.1080/03601277.2013.802186
Horváth, K. A., Ill, G., & Milánkovich, Á. (2017, July). Passive extended double-sided
two-way ranging algorithm for UWB positioning. In 2017 Ninth International
Conference on Ubiquitous and Future Networks (pp. 482–487).
https://doi.org/10.1109/ICUFN.2017.7993831
Huang, D., Sangthong, R., McNeil, E., Chongsuvivatwong, V., Zheng, W., & Yang, X.
(2013). Effects of a phone call intervention to promote adherence to antiretroviral
therapy and quality of life of HIV/AIDS patients in Baoshan, China: A
randomized controlled trial. AIDS Research and Treatment, 2013, 580974.
https://doi.org/10.1155/2013/580974
Hugtenburg, J. G., Timmers, L., Elders, P. J., Vervloet, M., & van Dijk, L. (2013).
Definitions, variants, and causes of nonadherence with medication: A challenge
for tailored interventions. Patient Preference and Adherence, 7, 675–682.
https://dx.doi.org/10.21472FPPA.S29549
Iuga, A. O., & McGuire, M. J. (2014). Adherence and health care costs. Risk
Management and Healthcare Policy, 7, 35–44.
https://doi.org/10.2147/RMHP.S19801
89
Gabbay, U., Yosef, N., Feder-Krengel, N., & Meyerovitch, J. (2012). Therapeutic
equivalent substitute that is new or unfamiliar to the chronic patient may result in
medication error. International Journal of Health care Quality Assurance, 25(6),
509–518. https://doi.org/10.1108/09526861211246467
Gee, P. M., Greenwood, D. A., Paterniti, D. A., Ward, D., & Miller, L. M. S. (2015). The
eHealth enhanced chronic care model: A theory derivation approach. Journal of
Medical Internet Research, 17(4), e86. https://doi.org/10.2196/jmir.4067
Kadam, P., & Bhalerao, S. (2010). Sample size calculation. International Journal of
Ayurveda Research, 1(1), 55–57. Retrieved from
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876926/
Karakurt, P., & Kaşikçi, M. (2012). Factors affecting medication adherence in patients
with hypertension. Journal of Vascular Nursing, 30(4), 118–126.
https://doi.org/10.1016/j.jvn.2012.04.002
Kaur, S. P. (2013). Variables in research. Indian Journal of Research and Reports in
Medical Sciences, 3(4), 36–38. Retrieved from http://rnc.fmrp.usp.br/wp-
content/uploads/complemento-aula-1.pdf
Kelly, P., Fitzsimons, C., & Baker, G. (2016). Should we reframe how we think about
physical activity and sedentary behaviour measurement? Validity and reliability
reconsidered. International Journal Of Behavioral Nutrition And Physical
Activity, 13(1). doi: 10.1186/s12966-016-0351-4
Khorsandi, M., Fekrizadeh, Z., & Roozbahani, N. (2017). Investigation of the effect of
education based on the health belief model on the adoption of hypertension-
controlling behaviors in the elderly. Clinical Interventions in Aging, 12, 233–240.
https://doi.org/10.2147/CIA.S117142
90
Kim, J., Combs, K., Downs, J., & Tillman, F. (2018). Medication adherence: The
elephant in the room. US Pharm, 43(1), 30-34. Retrieved from
https://www.uspharmacist.com/article/medication-adherence-the-elephant-in-the-
room
Kokturk, N., Polatli, M., Oguzulgen, I. K., Saleemi, S., Al Ghobain, M., Khan, J., ... & El
Hasnaoui, A. (2018). Adherence to COPD treatment in Turkey and Saudi Arabia:
results of the ADCARE study. International journal of chronic obstructive
pulmonary disease, 13, 1377. doi:10.2147/COPD.S150411
Kim, M., Hill, M., Bone, L., & Levine, D. (2000). Development and testing of the hill-
bone compliance to High Blood Pressure Therapy Scale. Progress in
Cardiovascular Nursing, 15(3), 90–96. https://doi.org/10.1111/j.1751-
7117.2000.tb00211.x
Kucukdagli, P., Bahat, G., Bay, I., Kilic, C., Oren, M. M., Turkmen, B. O., & Karan, M.
A. (2019). The relationship between common geriatric syndromes and potentially
inappropriate medication use among older adults. Aging Clinical and
Experimental Research, 2019, 1–7. https://doi.org/10.1007/s40520-019-01239-x
Kwan, A. (2012). Using mobile technologies for healthier aging. New York, NY:
mHealth Alliance and Pfizer.
Lam, W. Y., & Fresco, P. (2015). Medication adherence measures: An overview. BioMed
Research International, 2015, Article 217047.
https://doi.org/10.1155/2015/217047
91
Lamiani, G., Borghi, L., & Argentero, P. (2017). When healthcare professionals cannot
do the right thing: A systematic review of moral distress and its correlates.
Journal of Health Psychology, 22(1), 51–67.
https://doi.org/10.1177%2F1359105315595120
Lau, K. P., & Adewumi, A. D. (2019). Awareness and use of medication management
services in relation to medication adherence prior to hospitalization among older
adults in Regional Australia. International Journal of Clinical Pharmacy, 41(1),
189–197. https://doi.org/10.1007/s11096-018-0765-y
Lee, S., Jiang, L., Dowdy, D., Hong, Y. A., & Ory, M. G. (2018). Attitudes, beliefs, and
cost-related medication nonadherence among adults aged 65 or older with chronic
diseases. Preventing Chronic Disease, 15, E148.
https://doi.org/10.5888/pcd15.180190
Lemanek, K. L., & Yardley, H. (2019). Noncompliance and Nonadherence. In Handbook
of Cognitive Behavioral Therapy for Pediatric Medical Conditions (pp. 407-416).
Springer, Cham.
Lemstra, M., Nwankwo, C., Bird, Y., & Moraros, J. (2018). Primary nonadherence to
chronic disease medications: A meta-analysis. Patient Preference and Adherence,
12, 721–731. https://doi.org/10.2147/PPA.S161151
Leung, L. (2015). Validity, reliability, and generalizability in qualitative research.
Journal of Family Medicine and Primary Care, 4(3), 324–327.
https://dx.doi.org/10.4103%2F2249-4863.161306
92
Li, T., Vedula, S. S., Hadar, N., Parkin, C., Lau, J., & Dickersin, K. (2015). Innovations
in data collection, management, and archiving for systematic reviews. Annals of
Internal Medicine, 162(4), 287–294. Retrieved from https://annals.org/aim/article-
abstract/2118598
Li, X., & Haupt, J. (2016). Robust low-complexity randomized methods for locating
outliers in large matrices. Retrieved from https://arxiv.org/abs/1612.02334
Lum, Z. K., Suministrado, M. S. P., Venketasubramanian, N., Ikram, M. K., & Chen, C.
(2019). Medication compliance in Singaporean patients with Alzheimer’s disease.
Singapore Medical Journal, 60(3), 154–169.
https://dx.doi.org/10.11622%2Fsmedj.2018076
Luquis, R. R., & Kensinger, W. S. (2019). Applying the health belief model to assess
prevention services among young adults. International Journal of Health
Promotion and Education, 57(1), 37–47.
https://doi.org/10.1080/14635240.2018.1549958
Lyons, I., Barber, N., Raynor, D. K., & Wei, L. (2016). The Medicines Advice Service
Evaluation (MASE): A randomized controlled trial of a pharmacist-led telephone-
based intervention designed to improve medication adherence. BMJ QualSaf,
25(10), 759–769. https://doi.org/10.1136/bmjqs-2015-004670
Marcucci, M., Iorio, A., Nobili, A., Tettamanti, M., Pasina, L., Marengoni, A., . . .
REPOSI Investigators. (2010). Factors affecting adherence to guidelines for
antithrombotic therapy in elderly patients with atrial fibrillation admitted to
internal medicine wards. European Journal of Internal Medicine, 21(6), 516–523.
https://doi.org/10.1016/j.ejim.2010.07.014
93
Marcum, Z. A., Hanlon, J. T., & Murray, M. D. (2017). Improving medication adherence
and health outcomes in older adults: An evidence-based review of randomized
controlled trials. Drugs & Aging, 34(3), 191–201. https://doi.org/10.1007/s40266-
016-0433-7
Mayeye, B. F., Ter Goon, D., & Yako, E. M. (2019). An Exploratory Study of the
Determinants of Adherence to Antiretroviral Therapy by Adolescents and Youths
in the Eastern Cape, South Africa. Global Journal of Health Science, 11(11).
doi:10.5539/gjhs.v11n11p141
Mayo-G, T. L., & Mouton, C. (2017). Examining the association between health literacy
and medication adherence among older adults. Journal of Health Communication,
33(9), 1124–1130. https://doi.org/10.1080/10410236.2017.1331311
Mazhar, F., Akram, S., Malhi, S. M., & Haider, N. (2018). A prevalence study of
potentially inappropriate medications use in hospitalized Pakistani elderly. Aging
Clinical and Experimental Research, 30(1), 53–60.
https://doi.org/10.1007/s40520-017-0742-7
McMullen, C. K., Safford, M. M., Bosworth, H. B., Phansalkar, S., Leong, A., Fagan, M.
B., . . . Brinkman, W. B. (2015). Patient-centered priorities for improving
medication management and adherence. Patient Education and Counseling,
98(1), 102–110. https://doi-org.lopes.idm.oclc.org/10.1016/j.pec.2014.09.015
Melchiorre, M. G., Papa, R., Rijken, M., van Ginneken, E., Hujala, A., & Barbabella, F.
(2018). eHealth in integrated care programs for people with multimorbidity in
Europe: Insights from the ICARE4EU project. Health Policy, 122(1), 53–63.
https://doi.org/10.1016/j.healthpol.2017.08.006
94
Midão, L., Giardini, A., Menditto, E., Kardas, P., & Costa, E. (2017). Adherence to
medication in older adults as a way to improve health outcomes and reduce
healthcare system spending. In G. D’Onofrio, D. Sancarlo, & A. Greco (Eds.),
Gerontology (pp. 25–40). https://doi.org/10.5772/intechopen.72070
Miller, T. A. (2016). Health literacy and adherence to medical treatment in chronic and
acute illness: A meta-analysis. Patient Education and Counseling, 99(7), 1079-
1086. https://doi.org/10.1016/j.pec.2016.01.020
Mirhoseni, S. J., Mazloomy, S., & Moqaddasi Amiri, M. (2019). The study of blood
pressure related factors based on health belief model in Yazd in 2017.
Tolooebehdasht, 18(4), 107–119. Retrieved from http://tbj.ssu.ac.ir/article-1-
2980-en.html
Mitchell, T. R. (1985). An evaluation of the validity of correlational research conducted
in organizations. Academy of Management Review, 10(2), 192–205.
https://doi.org/10.5465/amr.1985.4277939
Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. (2018). Predictive validity of a
medication adherence measure in an outpatient setting. Journal of Clinical
Hypertension, 10(5), 348–354. https://doi.org/10.1111/j.1751-7176.2008.07572.x
Morrissey, E. C., Casey, M., Glynn, L. G., Walsh, J. C., & Molloy, G. J. (2018).
Smartphone apps for improving medication adherence in hypertension: Patients’
perspectives. Patient Preference and Adherence, 12, 813–822.
https://dx.doi.org/10.21472FPPA.S145647
95
Nguyen, T., La Caze, A., & Cottrell, N. (2016). Validated adherence scales used in a
measurement-guided medication management approach to target and tailor a
medication adherence intervention: A randomized controlled trial. BMJ Open,
6(11), e013375. https://doi.org/10.1136/bmjopen-2016-013375
O’Quinn, K. E., Semalulu, T., & Orom, H. (2015). Elder and caregiver solutions to
improve medication adherence. Health Education Research, 30(2), 323–335.
https://doi.org/10.1093/her/cyv009
Pagès-Puigdemont, N., Mangues, M. A., Masip, M., Gabriele, G., Fernández-Maldonado,
L., Blancafort, S., & Tuneu, L. (2016). Patients' perspective of medication
adherence in chronic conditions: A qualitative study. Advances in Therapy,
33(10), 1740–1754. https://doi.org/10.1007/s12325-016-0394-6
Pandis, N. (2016). Linear regression. American Journal of Orthodontics and Dentofacial
Orthopedics, 149(3), 431–434. https://doi.org/10.1016/j.ajodo.2015.11.019
Park, L., Howie-Esquivel, J., & Dracup, K. (2014). A quantitative systematic review of
the efficacy of mobile phone interventions to improve medication adherence.
Journal of Advanced Nursing, 70(9), 1932–1953.
https://doi.org/10.1111/jan.12400
Patton, D. E., Hughes, C. M., Cadogan, C. A., & Ryan, C. A. (2017). Theory-based
interventions to improve medication adherence in older adults prescribed
polypharmacy: A systematic review. Drugs & Aging, 34(2), 97–113.
https://doi.org/10.1007/s40266-016-0426-6
96
Pednekar, P. (2019). The impact of medication adherence on healthcare utilization and
costs among elderly patients with diabetes who were enrolled in a state
pharmaceutical assistance program (Doctoral dissertation, University of the
Sciences in Philadelphia). Retrieved from ProQuest Dissertations. (UMI No.
13856162)
Piette, J. D., Beard, A., Rosland, A. M., & McHorney, C. A. (2011). Beliefs that
influence cost-related medication non-adherence among the “haves” and “have
nots” with chronic diseases. Patient Preference and Adherence, 5, 389–396.
https://dx.doi.org/10.21472FPPA.S23111
Ponto, J. (2015). Understanding and evaluating survey research. Journal of the Advanced
Practitioner in Oncology, 6(2), 168–171. Retrieved from
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601897/
Prayaga, R. B., Jeong, E. W., Feger, E., Noble, H. K., Kmiec, M., & Prayaga, R. S.
(2018).Improving refill adherence in Medicare patients with tailored and
interactive mobile text messaging: Pilot study. JMIR mHealth and uHealth, 6(1),
e30. https://doi.org/10.2196/mhealth.8930
Provost, S. M., Lanham, H. J., Leykum, L. K., McDaniel, R. R., Jr., & Pugh, J. (2015).
Health care huddles: Managing complexity to achieve high reliability. Health
Care Management Review, 40(1), 2–12.
https://doi.org/10.1097/HMR.0000000000000009
Qato, D. M., Wilder, J., Schumm, L. P., Gillet, V., & Alexander, G. C. (2016). Changes
in prescription and over-the-counter medication and dietary supplement use
among older adults in the United States, 2005 vs 2011. JAMA Internal Medicine,
176(4), 473–482. https://doi.org/10.1001/jamainternmed.2015.8581
97
Raghupathi, W., & Raghupathi, V. (2018). An empirical study of chronic diseases in the
United States: A visual analytics approach. International Journal of
Environmental Research and Public Health, 15(3), 431.
https://doi.org/10.3390/ijerph15030431
Rasu, R. S., Bawa, W. A., Suminski, R., Snella, K., & Warady, B. (2015). Health literacy
impact on national healthcare utilization and expenditure. International Journal
of Health Policy and Management, 4(11), 747–755.
https://doi.org/10.15171/ijhpm.2015.151
Redston, M. R., Hilmer, S. N., McLachlan, A. J., Clough, A. J., & Gnjidic, D. (2018).
Prevalence of potentially inappropriate medication use in older inpatients with
and without cognitive impairment: A systematic review. Journal of Alzheimer's
Disease, 61(4), 1639–1652. https://doi.org/10.3233/JAD-170842
Rivera, S. C., Kyte, D. G., Aiyegbusi, O. L., Keeley, T. J., & Calvert, M. J. (2017).
Assessing the impact of healthcare research: A systematic review of
methodological frameworks. PLoS Medicine, 14(8), e1002370.
https://dx.doi.org/10.1371%2Fjournal.pmed.1002370
Rochon, P. A. (2019). Drug prescribing for older adults. UpToDate. Retrieved from
https://www.uptodate.com/contents/drug-prescribing-for-older-adults
Rocque, G. B., Pisu, M., Jackson, B. E., Kvale, E. A., Demark-Wahnefried, W., Martin,
M. Y., . . . Williams, C. P. (2017). Resource use and Medicare costs during lay
navigation for geriatric patients with cancer. JAMA Oncology, 3(6), 817–825.
https://doi.org/10.1001/jamaoncol.2016.6307
98
Rosenstock, I. M. (1990). The health belief model: Explaining health behavior through
expectancies. In K. Glanz, F. M. Lewis, & B. K. Rimer (Eds.), The Jossey-Bass
health series. Health behavior and health education: Theory, research, and
practice (p. 39–62). Jossey-Bass.
Rubin, R. (2019). Synchronizing medication refills could improve adherence. JAMA,
322(8), 716–716. https://doi.org/10.1001/jama.2019.12349
Saragosa M., Carbone, S., King, M., Poole, M., Peckham, A., Allin, S., & Marchildon, G.
(2020). Using Technology to Support Home and Community Care in Rural Areas.
Toronto: North American Observatory on Health Systems and Policies. Rapid
Review, 20. Retrieved from
https://ihpme.utoronto.ca/wp-content/uploads/2020/01/NAO-Rapid-Review-
20_EN.pdf
ShafieeHanjani, L., Apostolidis, A., Winckel, K., & Burrows, J. A. (2017). An evaluation
of the utilization of the Medication Action Plan form in a tertiary hospital: What
is the impact of the pharmacist? Journal of Pharmacy Practice and Research,
47(4), 257–262. https://onlinelibrary.wiley.com/journal/20552335
Shruthi, R., Jyothi, R., Pundarikaksha, H. P., Nagesh, G. N., & Tushar, T. J. (2016). A
study of medication compliance in geriatric patients with chronic illnesses at a
tertiary care hospital. Journal of Clinical and Diagnostic Research: JCDR,
10(12), FC40–FC43. https://doi.org/10.7860/JCDR/2016/21908.9088
Siddiqui, A., Siddiqui, A. S., Jawaid, M., & Zaman, K. A. (2017). Physician’s perception
versus patient’s actual incidence of drug non-adherence in chronic illnesses.
Cureus, 9(11), e1893. https://dx.doi.org/10.7759%2Fcureus.1893
99
Simon, M. K., & Goes, J. (2013). Assumptions, limitations, delimitations, and scope of
the study. Retrieved from http://www.dissertation recipes.com
Sinan, O., & Akyuz, A. (2019). Effects of home visits on medication adherence of elderly
individuals with diabetes and hypertension. Eastern Journal of Medicine, 24(1),
8–14. https://doi.org/10.5505/ejm.2019.71463
Siu, H. Y. H., Delleman, B., Langevin, J., Mangin, D., Howard, M., Fang, Q., . . . Chan,
D. (2019). Demonstrating a technology-mediated intervention to support
medication adherence in community-dwelling older adults in primary care: A
feasibility study. Gerontology and Geriatric Medicine, 5, 2333721419845179.
https://doi.org/10.11772F2333721419845179
Smith, D., Lovell, J., Weller, C., Kennedy, B., Winbolt, M., Young, C., & Ibrahim, J.
(2017). A systematic review of medication nonadherence in persons with
dementia or cognitive impairment. PLoS ONE, 12(2), 1–19.
https://doi.org/10.1371/journal.pone.0170651
Soones, T. N., Lin, J. L., Wolf, M. S., O’Conor, R., Martynenko, M., Wisnivesky, J. P.,
& Federman, A. D. (2017). Pathways linking health literacy, health beliefs, and
cognition to medication adherence in older adults with asthma. Journal of Allergy
and Clinical Immunology, 139(3), 804–809. doi:10.1016/j.jaci.2016.05.043
Steele, K. M., Ruisinger, J. F., Bates, J., Prohaska, E. S., Melton, B. L., & Hipp, S.
(2016). Home-based comprehensive medication reviews: Pharmacist's impact on
drug therapy problems in geriatric patients. The Consultant Pharmacist®, 31(10),
598–605. https://doi.org/10.4140/TCP.n.2016.598
100
Subramanyam, A. A., Singh, S., & Raut, N. B. (2018). Mobile phone use in the elderly:
Boon or bane? Journal of Geriatric Mental Health, 5(2), 81.
https://doi.org/10.4103/jgmh.jgmh_32_18
Sultan, M. (2016). Informing the design of a smartphone-based telemonitoring system for
multiple chronic conditions (Doctoral dissertation). Retrieved from
https://www.semanticscholar.org/paper/Informing-the-Design-of-a-Smartphone-
Based-System-Sultan/5c3af435ddb7d767aeb28f207e742a52b0c91f27
Tabachnick, B. G. & Fidell, L. S. (2013). Using multivariate statistics (6th ed.) Boston,
MA: Pearson.
Thakkar, J., Kurup, R., Laba, T. L., Santo, K., Thiagalingam, A., Rodgers, A., & Chow,
C. K. (2016). Mobile telephone text messaging for medication adherence in chronic
disease: A meta-analysis. JAMA Internal Medicine, 176(3), 340–349.
https://doi.org/10.1001/jamainternmed.2015.7667
Theofanidis, D., &Fountouki, A. (2018). Limitations and delimitations in the research
process. Perioperative Nursing, 7(3), 155–163. https://doi-
org.lopes.idm.oclc.org/10.5281/zenodo.2552022
Toll, B. A., McKee, S. A., Martin, D. J., Jatlow, P., & O'Malley, S. S. (2007). Factor
structure and validity of the Medication Adherence Questionnaire (MAQ) with
cigarette smokers trying to quit. nicotine & tobacco research. Official Journal of
the Society for Research on Nicotine and Tobacco, 9(5), 597–605.
https://doi.org/10.1080/14622200701239662
101
Tse, G., Chan, C., Gong, M., Meng, L., Zhang, J., Su, X. L., ... & Zhao, J. C. (2018).
Telemonitoring and hemodynamic monitoring to reduce hospitalization rates in
heart failure: a systematic review and meta-analysis of randomized controlled
trials and real-world studies. Journal of geriatric cardiology: JGC, 15(4), 298.
doi:10.11909/j.issn.1671-5411.2018.04.008
Turner, A. P., Roubinov, D. S., Atkins, D. C., & Haselkorn, J. K. (2016). Predicting
medication adherence in multiple sclerosis using telephone-based home
monitoring. Disability and Health Journal, 9(1), 83–89.
https://doi.org/10.1016/j.dhjo.2015.08.008
Ueno, H., Yamazaki, Y., Yonekura, Y., Park, M. J., Ishikawa, H., & Kiuchi, T. (2018).
Reliability and validity of a 12-item medication adherence scale for patients with
chronic disease in Japan. BioMed Central Health Services Research, 18(1),
Article 592. https://doi.org/10.1186/s12913-018-3380-7
Unutmaz, G. D., Soysal, P., Tuven, B., & Isik, A. T. (2018). Costs of medication in older
patients: Before and after comprehensive geriatric assessment. Clinical
Interventions in Aging, 13(2), 607–622.
https://dx.doi.org/10.21472FCIA.S159966
Van Boven, J. F. M., Cushen, B., Sulaiman, I., Greene, G., MacHale, E., Mokoka, M. C.,
… Costello, R. W. (2018). Personalising adherence-enhancing interventions using
a smart inhaler in patients with COPD: an exploratory cost-effectiveness analysis.
Npj Primary Care Respiratory Medicine, 28(1). doi:10.1038/s41533-018-0092-8
102
Van den Broucke, S., Dargent, G., & Pletschette, M. (2011). Development and
assessment of criteria to select projects for funding in the EU health programme.
The European Journal of Public Health, 22(4), 598–601.
https://doi.org/10.093/reseval/rvz007
Verloo, H., Chiolero, A., Kiszio, B., Kampel, T., & Santschi, V. (2017). Nurse
interventions to improve medication adherence among discharged older adults: A
systematic review. Age & Ageing, 46(5), 747–754. https://doi-
org.lopes.idm.oclc.org/10.1093/ageing/afx076
Wamala, S., Merlo, J., Bostrom, G., Hogstedt, C., & Agren, G. (2007). Socioeconomic
disadvantage and primary non-adherence with medication in Sweden.
International Journal for Quality in Health Care, 19(3), 134–140.
https://doi.org/10.1093/intqhc/mzm011
Watson, R. (2015). Quantitative research. Nursing Standard, 29(31).
https://doi.org/10.7748/ns
Yang, P., Stankevicius, D., Marozas, V., Deng, Z., Liu, E., Lukosevicius, A., . . . Min, G.
(2016). Lifelogging data validation model for internet of things enabled
personalized healthcare. Institute of Electrical and Electronics Engineers
Transactions on Systems, Man, and Cybernetics: Systems, 48(1), 50–64.
https://doi.org/10.1109/TSMC.2016.2586075
Yap, A. F., Thirumoorthy, T., & Kwan, Y. H. (2016). Medication adherence in the
elderly. Journal of Clinical Gerontology and Geriatrics, 7(2), 64–67.
https://doi.org/10.1016/j.jcgg.2015.05.001
103
Yap, A. F., Thirumoorthy, T., & Kwan, Y. H. (2016). Systematic review of the barriers
affecting medication adherence in older adults. Geriatrics & Gerontology
International, 16(10), 1093–1101. https://doi.org/10.1111/ggi.12616
Yazdanpanah, Y., Saleh Moghadam, A. R., Mazlom, S. R., Haji Ali Beigloo, R., &
Mohajer, S. (2019). Effect of an educational program based on health belief
model on medication adherence in elderly patients with hypertension. Evidence
Based Care, 9(1), 52–62. Retrieved from
http://ebcj.mums.ac.ir/article_12731.html
Yeon Park, H., Ae Seo, S., Yoo, H., & Lee, K. (2018). Medication adherence and beliefs
about medication in elderly patients living alone with chronic diseases. Patient
Preference and Adherence, 12, 175–181. https://doi-org.lopes.idm.oclc.org/
10.2147/PPA.S151263
Yip, C., Han, N. R., & Sng, B. L. (2016). Legal and ethical issues in research. Indian
Journal of Anesthesia, 60(9), 684–688. doi:10.4103/0019-5049.190627
104
Appendix A
GCU IRB Letter of Approval
105
1
Appendix B
HILL-BONE MEDICATION ADHERENCE SCALE(HB-MAS)
None of the time= 1, Some of the time=2, Most of the time =3 All the time=4,
1-How often do you forget to take your medicine 1 2 3 4
2-How often do you decide not to take your medicine 1 2 3 4
3-How often do you miss taking your meds when you feel better 1 2 3 4
4-How often do you miss taking your meds when you feel sick 1 2 3 4
5-How often do you miss taking your meds when you care less 1 2 3 4
2
Appendix C
Permission Letter
THANK YOU FOR YOUR INTEREST IN USING THE HILL-BONE
SCALE.
SCORING GUIDE the validation and use of the scale. We would like to
request that you cite the scale using the references provided. We would appreciate you
sharing the findings of your research with us.
Please don't hesitate to reach out to us at [email protected] if you have any follow-up questions.